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Abstract
A 5 km cycling time trial (TT) demands high, sustained muscle power output and
substantial oxidative and glycolytic energy delivery. The aims of this study were to firstly
use the novel approach of using Peak Sustained Power Output (PSPO) as a predictor of
cycling performance for variable fixed-workload testing and 5 km time trialing and
whether oral creatine supplementation would affect 5 km time trial performance and
metabolism. The effect of oral creatine supplementation with 20 g/day for 7 days on 5 km
time trial performance and metabolism after a random-variable workload protocol
(stochastic test) was investigated in a single-blind placebo controlled study. Thirteen
trained male cyclists volunteered for the study that was approved by the University of
Stellenbosch Research Ethics Committee. We hypothesized that Cr supplementation
would affect time trial performance as well as the appearance of breakdown products of
adenine nucleotides in the plasma. Baseline: the subjects' peak power output was
measured and they underwent a baseline stochastic test followed immediately by a 5 km
time trial (STI) and on a different day, a single 5 km time trial test (Tl) was undertaken.
Study 1: In the following week the subjects repeated the stochastic test with 5 km time
trial (ST2) and on a different day a 5 km time trial (T2). During T2 blood samples were
taken at regular intervals as well as during recovery. A muscle biopsy was taken after T2
in the recovered state. The major performance predictors were the 5-km time trials (TTl
and TT2) with a coefficient of variation between the thirteen trained male cyclists of
0.6%. The 5 km time trials in the fatigued state (STI and ST2) had a coefficient of
variation of 0.7%. Results: There was a significant difference between 5 km TT
performed fresh and 5km TT performed fatigued (P=0.0001). The decrement in time
ranged between 1.0 sec to 38.0 sec. The relationship between two different high intensity
endurance performance tests: PSPO and 5 km TT (TT mean) had a correlation ofr=-0.79
P<O.OI. The correlation between PSPO and the 5 km TT performed in the fatigued
condition (ST mean) was r= -0.60 P<0.05. There was also a relationship between age and
PSPO (F 0.73; P<0.05). Age showed a good negative relationship with TT mean (F-
0.71; P<0.05). Mass and PSPO were also correlated (FO.85; P<O.OI). Plasma lactate
concentrations were significantly different from rest at all other time points P<O.OOOIup
to 20 minutes post-exercise. Hypoxanthine (P<O.OOOI)and urate (P=O.05) concentrations
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were also significantly different from rest at all other time points. There was a significant
change in plasma hypoxanthine concentrations over time (P<0.0001). There was a
significant correlation between plasma lactate concentration at time 0 in recovery and %
Myosin Heavy Chain (MHC) I (FO.59, P<0.05) and % MHC na (F -0.61, P<0.05). Area
under the curve for hypoxanthine showed significant relationships of F -0.53 (P=O.05)
and F 0.56 (P<0.05) respectively for %MHC I and %MHC ITa. Study 2 -
Supplementation: following T2 the subjects received Cr or placebo powder containing
sachets to be ingested 4 times daily for the next week with carbohydrate also provided.
Post-supplementation testing: the subjects returned and conducted another variable fixed-
workload test with 5 km time trial (ST3) as well as a single 5 km time trial (T3). They
once again underwent the same blood sampling routine and had another muscle biopsy in
the rested state. The average of ST1 and ST2 was used as the major measure for
performance under fatigued conditions and TTmean. Results: there was a significant
difference between 5 km TT performed fresh and 5 km TT performed fatigued
(P=0.0001). Plasma lactate, hypoxanthine and urate samples were taken at the post-
loading 5 km time trial (TT3). The levels of these plasma metabolites were compared to
the concentrations of those sampled at TT2 and between the creatine and placebo groups.
The plasma hypoxanthine levels were significantly different from rest for both the
creatine and placebo groups (P<0.0001). Plasma urate had significant change in
concentrations over the time points (P<0.005). Another significant difference was found
between the creatine and placebo groups for the pre-and post tests conducted (P<0.005).
The creatine group showed a non-significant increase (7%) in mean total intramuscular
creatine concentration. No significant differences were found in the mean values for total
nucleotide concentration pre- and post loading in the creatine and placebo groups.
Conclusions: The 5 km performance test resulted in high values for plasma lactate,
hypoxanthine and urate, an indication of fatigue induced by this performance test. Oral
creatine supplementation did not improve performance significantly in the variable fixed-
workload protocol 5 km time trials or the individual 5-km time trials and had an effect on
adenine nucleotide metabolism in both the variable fixed-workload protocol 5-km time
trial and individual 5 km time trial performance tests.
3
Stellenbosch University http://scholar.sun.ac.za
OPSOMMING
Die 5 km fietsry tyd toets (TT) verg hoëvolgehoue, spierkrag en wesenlike oksidatiewe
en glikolitiese energie verskaffing. Die doelwitte van hierdie tesis was eerstens om 'n
nuwe fietsergometer toets te ontwerp vir die voorspelling van kompetisie prestasie. Die
toets was 'n veranderlike, voorafvasgestelde werkladingstoets (VVWT). Dit is vergelyk
met 'n maksimale volgehoue kraguitsetingstoets (MVKT) en 'n 5 km TT. Daarna is
bepaal ofkreatien supplementasie 'n effek sou hê op enige van hierdie oefeningstoetse of
metabolisme tydens die 5 km TT. Die supplementasie eksperiment was 'n enkelblinde,
plasebo-gekontroleerde studie ontwerp. Dertien manlike fietsryers het vrywilliglik
deelgeneem. Resultate: Daar was 'n statisties betekenisvolle verskil tussen die 5 km TT
wat vars onderneem is en die wat direk na die VVWT onderneem is (P=O.OOOl). Daar
was ook 'n betekenisvolle korrelasie tussen die twee verskillende hoë intensiteit kort-
tydsvak oefeningstoetse (r=-0.79 P<O.Ol vir TT en MVKT). Plasma laktaat konsentrasies
was betekenisvol verhoog met vergelyking van die monsters geneem tydens rus en all
ander onteledings tydspunte (P<0.0001) tot en met 20 minute na oefening. Hypoxantien
(P<O.OOOl) en uraat (P=0.05) konsentrasies was ook betekenisvol verskillend van rus by
alle ander tysdpunte. Daar was 'n betekenisvolle korrelasie tussen plasma laktaat direk na
oefening en die % Myosien Swaarketting (MIlC) I (r=0.59, P<0.05) en % MHC ITa (r= -
0.61, P<0.05). Studie 2 - Na supplementasie was daar geen verskil in oefeningsprestasie
nie maar wel in plasma metaboliet waardes van nie. Gevolgtrekkings: Die 5 km TT het
baie hoë waardes vir plasma laktaat tot gevolg gehad, asook hypoxantien en uraat, 'n
indikasie van die hoë mate van vermoeienis deur hierdie oefeningtoets berwerkstellig.
Kreatine supplementasie kon nie oefeningsprestasie verbeter nie.
4
Stellenbosch University http://scholar.sun.ac.za
Acknowledgements
I would like to start by thanking Dr. Kathy Myburgh for having taken me under her wing
and helping me through my Masters. Thank you for all the valuable knowledge you have
given me and for being a great supervisor.
Secondly, I would like to thank Tertius Kohn for teaching me how to do gels and lab
techniques and it was great having you as a colleague. A special thanks to Carine Smith
who helped me when ever I required it and for teaching me the histology techniques, I
really appreciated it Thanks to Paula Robson for being a great colleague and friend and
for the initial help with my statistics.
A special appreciation and thank you to Gary Wilson from the University of Cape Town
for all the hours you spent helping me setting up the HPLC and for teaching me how to
use it
Thank you to Dr. Koenig for performing all the biopsies and especially for those after
hour appointments. In addition thank you to Dr Jos du Toit for teaching me how to use
the freeze-dryer. A great appreciation goes out to Dr. Lize van der Merwe from the
statistics department for teaching me the more complex of statistical analyses. A special
thanks to the MRC for the funding of the study.
A very special thank you must go to all my subjects. Without you this project would have
not been possible, I really appreciate all your cooperation and patience during the testing.
Last, but certainly not least, an extra special thank you to my parents who have made my
education possible. Thank you for all your guidance, patience and knowledge you have
given me during my extended studies, I am forever indebted. This thesis is dedicated to
you both.
5
Stellenbosch University http://scholar.sun.ac.za
Abbreviations
PSPO - Peak Sustained Power Output
MIlC - Myosin Heavy Chain
ATP - Adenosine 5' - triphosphate
ADP - Adenosine 5'- diphosphate
AMP - Adenosine 5' -monophosphate
TCr - Total creatine
PCr - Phosphocreatine
Cr - Creatine
CP - Creatine Phosphate
V02max - Maximal Oxygen Uptake
Na+- Sodium ions
K+ - Pottasium ions
ST - Slow twitch
FT - Fast Twitch
MATPase - Myosin Adenosine Triphosphatase
Pi - inorganic phosphate
Sec - seconds
G6-P - Glucose-6-phosphate
GI-P - Glucose-I-phosphate
F6-P - Fructose-6-phosphate
PFK - Phosphofructokinase
PEP - Phosphoenolpyruvate
PNC - Purine Nucleotide Cycle
IMP - Inosine 5' - monophosphate
Acetyl-CoA - Acetyl Coenzyme A
GDP - Guanosine diphosphate
GTP - Guanosine triphosphate
FAD - Flavin Adenine Dinucleotide
AnGP - Anaerobic glycolytic pathway
6
Stellenbosch University http://scholar.sun.ac.za
FFA - Free fatty acids
SNS - Sympathetic nervous system
Min - minutes
RER - Respirtory Exchange Ratio
GI - Glycemic index
BCAA - Branched Chain Amino Acids
LT - Lactate Threshold
NMR - Nuclear Magnetic Resonenee
SAM - S-adenosylmethione
GAA - Guanidinoacetic acid
Crea T - Creatine transporter
CK - Creatine Kinase
GPA - 3-guanidinopropionate
CHO - Carbohydrate
HPLC - High-Performance Liquid Chromatography
SD - Standard Deviation
Tables
Table 2.3.2 - The fibre type ratio for various disiplines
Table 3.3.1 - The relationship between various cycling events and energy requirements
Table 3.4.1 - The energy yield requirements for cycling
Table 3.5.1 - Early studies on sources of energy used to exercise
Table 4.1 - Commonly used lactate parameters
Table 5.3.1 - Creatine concentrations in selected uncooked food items
Table 5.5.1 - Successful creatine supplementation studies that used muscle biopsies to
check the extent of the increase in muscle Creatine and/or creatine phosphate levles
Table 5.5.4 - The concerns regarding the effects oral creatine supplementation
Table 5.6.1 - The effect of creatine monohydrate supplementation on various short term,
high intensity « 30 sec) cycle ergometer protocols on exercise performance
7
Stellenbosch University http://scholar.sun.ac.za
Table 5.6.2 - The effect of creatine monohydrate supplementation on various short term,
high intensity, more prolonged (> 30 to < 150 sec) cycle ergometer protocols on exercise
performance
Table 5.6.3 - The effect of creatine monohydrate supplementation on various short term,
high intensity, aerobic (> 150 sec) cycle ergometer protocols on exercise performance
Table 1 (results) - Subject characteristics
Table 2 (results) - Non-significant correlations between 105 km race time and different
laboratory measures of exercise performance
Table 3 (results) - Non-significant correlations between %MHC composition and
exercise performance variables
Table 4 (results) - Subject characteristics for the creatine (n=7) and placebo (n=6) groups
Figures
Fig 1 - The 5-km time trial performances
Fig 2 - The concentrations of plasma lactate before, during and after TT2
Fig 3 - The concentration of plasma hypoxanthine before and after TT2
Fig 4 - The concentration of plasma urate before and after TT2
Fig 5 - Individual curves for the subjects (n=13) for plasma lactate concentration
Fig 6 - The comparison of 5 km time trial performance for the creatine (n=7) and placebo
(n=6) groups before and after 7 days of creatine loading or placebo.
Fig 7 - The comparison between 5 km time trial performance times in the fatigued state
between the placebo (n=6) and creatine (n=7) groups before and after 7 days of creatine
loading and placebo.
Fig 8 - The comparison of plasma hypoxanthine concentrations pre- and post the 7 day
loading period in the placebo (n=6) and creatine (n=7) groups
Fig 9 - The comparison between plasma urate concentrations pre-and post the 7-day
loading period in the placebo (n=6) and creatine groups (n=7)
Fig 10 - Intramuscular total creatine concentration (mean and SD) in both the placebo
(n=6) and creatine groups (n=4) pre-and post supplementation
Fig 11 - The % MHC distribution between the creatine (n=7) and placebo groups (n=6)
8
Stellenbosch University http://scholar.sun.ac.za
Table of Contents
Page
Declaration 1
Abstract 2
Opsomming 4
Acknowledgements 5
Abbreviations 6
T~~ 7
Figures 8
Chapter 1: Introduction 9
Chapter 2: Predictors of Cycling Performance 11
2.1 The Cardio-respiratory System 11
2.2 Body Mass 13
2.3 Muscle 14
2.3.1 Muscle fiber types 15
2.3.2 Muscle fiber composition and cycling 17
Chapter 3: The Energy systems 21
3.1 The Phosphagen system 22
3.2 The Anaerobic Glycolytic system 24
3.3 The Aerobic System 28
3.4 The Energy Systems and Short Duration, High Intensity Cycling 32
3.5 Nutritional Intervention 34
Chapter4: Changes in plasma metabolite concentrations in cyclists 40
4.1 Lactate 40
4.2 The Purine Nucleotide cycle 43
Stellenbosch University http://scholar.sun.ac.za
Chapter 5: Creatine 46
5.1 Historical Background 46
5.2 Biosynthesis 48
5.2.1 Biochemistry 48
5.2.2 De Novo Synthesis 50
5.2.3 Creatine Transporters and Uptake 51
5.3 Creatine skeletal muscle 53
5.3.1 Distribution in the body and daily turnover 53
5.3.2 Gender and age 54
5.3.3 Creatine and muscle fibre types 55
5.4 Creatine Metabolism 56
5.4.1 Creatine and creatine phosphate as a temporal energy buffer 56
5.4.2 Creatine/creatine phosphate as a spatial energy buffer: The shuttle 56
5.5 Creatine supplementation 57
5.5.1 Dosing and the effects on muscle [TCr] and [PCr] 57
5.5.2 Caffeine and creatine supplementation 59
5.5.3 The effects of creatine on body composition 60
5.5.4 Potential side effects of creatine supplementation 61
5.5.5 Ethics and legality 63
5.6 Creatine and exercise performance 63
5.6.1 High intensity, short term exercise 63
5.6.2 High intensity, endurance exercise 66
Chapter 6: Aims 73
Chapter 7: Methods and Materials 74
7.1 Subjects and ethical approval 74
7.2 Experimental procedure 74
7.3 The Peak Power Output (PPO) Test 76
7.4 The Stochastic Test and 5-km Time Trials 77
7.5 Sample Handling and Analyses 78
Stellenbosch University http://scholar.sun.ac.za
7.5.1 Blood 78
7.5.2 Muscle 80
7.6 Statistical Analysis 83
Chapter 8: Results 84
8.1 Subjects 84
8.2 Study 1 85
8.2.1 Performance data 85
8.2.2 Relationship between different measures of exercise performance 86
8.2.3 Metabolic variables 87
8.2.4 Relationship between exercise performance (TI2) and metabolic variables 89
8.2.5 Muscle Physiology variables 90
8.3 Study 2 93
8.3.1 Nutritional intervention
8.3.2 Muscle data
95
97
Chapter 9: Discussion
9.1 Study 1
9.2 Study 2
9.3 Conclusion
100
100
105
109
References 110
Appendices
Appendix 1: Information sheet
Appendix 2: Consent form
Appendix 3: Stochastic test
Appendix 4: Freezing tissue for histochemistry
Appendix 5: Myosin ATPase staining procedure
Appendix 6: Muscle MHC separation using SDS-PAGE gels
Appendix 7: HPLC Chromatograms
125
126
127
131
132
133
135
136
Stellenbosch University http://scholar.sun.ac.za
Appendix 8: Table of means and SD
Appendix 9: Table of means and SD
Appendix 10: Table of means and SD
139
140
141
Stellenbosch University http://scholar.sun.ac.za
CHAPTER 1: Introduction
Many sports require the athlete to repeatedly engage in high-intensity exercise with
varying amounts of recovery time between bouts. Most of the energy for short bouts of
high-intensity exercise is derived from anaerobic sources and therefore the ability to
recover during rest periods is essential for success.
Physical activity results in the splitting of ATP in the exercising muscles. Because the
ATP stores are very limited the ATP broken down must be resynthesized continuously at
the same rate as it is used. At moderate exercise intensities, this resynthesis is
accomplished by aerobic processes. High-intensity exercise where the ATP-tumover rate
exceeds the maximal power of the oxygen transporting system is in addition heavily
dependent on anaerobic ATP-forming processes. The ability to exercise at high intensities
is therefore dependent on the capacities of both the aerobic and anaerobic processes
(Medbo and Tabata, 1989).
Exercise of high intensity may cause large increases in the adenosine 5' -triphosphate
(ATP) concentrations of skeletal muscle (Cheetham et al., 1986). Simultaneously an
increased production of adenosine 5' -diphosphate (ADP) activates adenylate kinase
which together with adenosine 5' -monophosphate deaminase maintains the balance of the
adenine nucleotide pool. The inosine monophosphate produced subsequently undergoes
oxidation and hypoxanthine is formed and has been shown that increased concentrations
of hypoxanthine in plasma following maximal short term running (Hellsten-Westing et
al., 1989). Hypoxanthine is then oxidized to urate, an irreversible reaction in human
tissue.
9
Stellenbosch University http://scholar.sun.ac.za
There has been a great deal of excitement amongst the scientific research family and
athletes about the dietary supplement creatine. Scientific research has shown that creatine
is not just an energy source that powers muscles, but it is more. Although creatine has
been known to man since 1832, its presence in athletes as a performance enhancer is
relatively new. Creatine has become the athlete's most important nutritional ergogenic
aid because (Juhn, 1999):
• There is a higher total creatine concentration [TCr] in skeletal muscle, including both
phosphocreatine [PCr] and free creatine [Cr], allowing for enhanced anaerobic ATP
production during maximal exercise.
• It enhances and accelerates the resynthesis of PCr during recovery periods between
bouts of intense exercise.
• Promotes significant increases in muscle size (lean body mass).
It should however be noted that the creatine phosphate (CP) reaction is anaerobic
(Bessman and Geiger, 1981), meaning that oral creatine supplementation is potentially
ergogenic only for activity that has a high anaerobic component, but not for endurance
activity (Balsom et al., 1993a). The possibility exists, however, that creatine may be
ergogenic for endurance events that involve intermittent bursts of anaerobic activity.
The purpose of this investigation was to study the performance of endurance cyclists in
high intensity, short duration endurance cycling. Another aim of the study was to
investigate the metabolic changes in the subjects performing such physical activities as
well as the effect of oral creatine supplementation on such a cycling protocol.
10
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Chapter 2: Predictors of Cycling Performance
H There seems to be no formula that determines a champion. Champions are born and
then made. This applies to all of us. We all need to work to be our best."
-Connie Carpenter-Phinney-
Competitive road cycling is very demanding physiologically and psychologically. A
cyclist is called upon to have stamina, strength and bursts of speed. The first challenge to
creating a successful training program and becoming a successful cyclist is to have a
better understanding of the required physiological and biochemical factors that affect
performance. Thus the factors that affect performance in cyclists and that will be
monitored in the research studies in this thesis, are the cardio-respiratory system, body
mass, muscle composition and muscle metabolism.
2.1 The Cardio-Respiratorv System
The key factor to performance in the cardio-respiratory system is maximal oxygen
utilization or V02max. It is traditionally defined as the maximal rate at which oxygen can
be taken up and used by the body during heavy, exhaustive aerobic exercise. It is
generally accepted as a good measure of the peak function of the cardiovascular system
of the test subject for the particular test protocol and often interpreted as an index of
cardio-respiratory fitness (Katch et al., 1982). Because oxygen is needed to convert fuel
(carb~hydrates and fats) into energy, the more oxygen you can use, the more energy you
can provide and the more energy you can produce the less likely you are to fatigue during
cycling.
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There are other determinants of maximal oxygen uptake. In the broadest sense, it is
determined by the maximal cardiac output and maximal arterio-venous oxygen partial
pressure difference, max PaOz - PvOz difference, as expressed in the following equation
(Snell and Mitchell, 1984):
VO zmax = max cardiac output x max PaOz - PvOz difference
One of the most fundamental beliefs in Exercise Physiology is that performance in
endurance exercise has a cardiovascular limitation, but it is possible that there is not a
cardiovascular limitation to exercise performance and that VOzmax is not a measure of a
physiological upper limit, rather it is a measure of the peak VOz at termination of a
particular test due to exhaustion. Thus, an alternative mechanism is needed to explain
exhaustion during maximal exercise performance. Noakes, (1988), proposed that the
factors limiting exercise might be better explained in terms of failure of muscle
contractility, which may be independent of tissue oxygen defi~iency. An increase in
oxygen consumption is due to increased workload and increased muscle cross-bridge
activity. This theory implies that the peak power output of the legs generated in the final
workload of the test is the more important variable instead of VOzmax.
Because there is a relationship between peak sustained power output (PSPO) and
VOzmax, shown by Noakes (1988), a theoretical VOzmax can be calculated using a
specific formula incorporating Peak Sustained Power Output (PSPO). The formula is as
follows:
VOzmax (calc) = 0.01141 x PSPO (W) + 0.435
(then, multiply by 1000 to convert the answer to ml/min/kg)
Elite road cyclists have some of the highest recorded values for maximal oxygen uptake.
Elite male and female cyclists range between 75 and 90 mlIkglmin and between 60 and
70 ml/kg/min respectively.
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Several studies have indicated the importance of maximal muscle power as a predictor of
athletic potential (Noakes et al., 1990; Hawley and Williams, 1991). If PSPO during
progressive exercise to exhaustion, or during maximal exercise of short duration is a
better predictor of endurance performance than V02max, the need to measure V02max
may be questioned. In a study by Hawley and Noakes, (1992), there were two important
findings. Firstly, there was a highly significant relationship between V02max and the
PSPO a cyclist could sustain during the final workload of the maximal test (r = 0.97,
P<O.OOOl).The second important finding of this study was the highly significant
relationship between PSPO and the performance time in a 20 km time trial (r = -0.91,
P<O.OOI),so that PSPO could explain 82% of the variance in times for a 20-km time trial.
2.2 Body Mass
Body mass is also an important factor in road cycling. It is important to relate body mass
to PSPO. In cycling, carrying extra mass is a definite disadvantage, especially when
climbing a hill and the power to weight ratio plays an important role. However a cyclist
-
also needs a specific amount of muscle mass for the power aspects of the sport, such as
time trials and sprints. Body mass alone is not an appropriate indicator of performance
potential. Body composition (the amount of fat and muscle) is also important.
Peak sustained power output can be considered as a dynamic measure of muscle mass
contributing to cycling performance. It is often related to body mass, i.e. PSPO/kg.
However, there is a poorer prediction for time trial performance when PSPO is related to
body mass. When PSPO was expressed relative to a cyclist's body mass, the correlation
between PSPO and the 20 km time decreased to 0.68 (P<O.OI) (Hawley and Noakes,
1992). This can probably be attributed to the flat time trial course used. Previous studies
have shown that body size and mass have an effect on energy cost of cycling. With a flat
course, wind resistance is by far the most important factor in slowing the cyclist down
and increasing the energy cost. Larger cyclists have more body surface and thus more
wind resistance than their smaller counterparts and thus need more energy to overcome
the higher wind resistance. But larger cyclists have greater absolute capacity to convert
13
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energy into power. So which factor wins? The disadvantage of a little extra wind
resistance is more than out weighed by the extra energy supplied by large cyclists on flat
surfaces (Swain et al., 1987). The advantage is lost when cycling uphill where gravity
plays the biggest role.
Peak sustained power output tests were conducted in this research study and were used to
predict time trial performance over a short course (5 km) and to determine sub-maximal
workloads for the variable fixed-workload cycling protocol. This points to another
advantage of PSPO over V02max. In contrast to V02max, which may drift during
exercise at a fixed workload, peak power output remains fixed when using an
electromagnetically braked cycle ergometer. Therefore, the workloads do not need to be
altered during a test to maintain a fixed V02max and baseline tests can be exactly
repeated later.
2.3 Muscle.
In addition to having a high V02max, the endurance and speed of the cyclist depends
largely on the muscles' ability to produce energy and force. Force originates at the
molecular level from the interaction of the major muscle proteins, actin and myosin in the
presence of ATP and Ca2+ (reviewed by Myburgh, 1994).
Intense contraction, particularly with large muscle groups, imposes a major strain on a
wide variety of physiological systems. To generate the high force levels accompanying
intense activity, maximal or near maximal activation of all the synergistic muscles is a
fundamental requirement (Green, 1997). In the case of cycling, seven different
synergistic muscles are recruited, their activation pattern being highly ordered and
dependent on the limb and pedal position during cycling (Green and Patla, 1992). At the
level of the individual muscle, maximal tetanic force for maximal work depends on full
recruitment of all motor units at high firing frequencies (Deluca, 1985). In terms of the
individual muscle cell, a successful response to the high firing frequencies is critically
14
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dependent on the sarcolemma and T-tubule system being able to regenerate action
potentials at high frequency to the interior of the cell. The ability to sustain multiple
action potentials is primarily dependent on the ability to get the pottasium ions (K+) back
into the cell from the interstitial space and to expel the excess sodium ions (Na+), which
enter during the action potential, back to the interstitial space. Control of the electro-
chemical gradients is primarily under the control of an electrogenic pump, which expends
energy in the form of ATP to pump both Na+and K+against their concentration gradients.
The enzyme involved, for hydrolyzing the ATP and producing the necessary energy for
this process is embedded in the membrane and is called the Na+/K+ - ATPase (Clausen
and Nielsen, 1994).
The movement of these molecules and subsequent depolarization of the sarcolemma and
t-tubules is believed to unblock the calcium release channel in the sarcoplasmic
reticulum, allowing calcium (Ca2+) to escape to the surrounding cytoplasm and result in
an increase in the concentration of free Ca2+. The generation of high force levels depends
on the Ca2+ signal begin translated via the regulatory proteins, troponin and tropomyosin,
leading to formation of the actomyosin bond and subsequent conformational change from
a weak binding to a dominant strong binding, force-generating state (Moss et al., 1995).
Weak to strong binding is mediated via activation of an ATPase, located in the myosin
heavy chains (MHC), which allows for the generation of free energy via ATP hydrolysis
and release of metabolic by-products, ADP and inorganic phosphate. As with
sarcolemma and T-tubules, continued excitation-contraction coupling relies on a cyclical
elevation of free Ca2+ for maximal activation of the myofibrillar apparatus.
2.3.1Muscle fibre types.
The functional, metabolic and molecular characteristics of skeletal muscle are quite
diverse. This diversity is in part due to the existence of different muscle fibre types
having particular characteristics and found in different proportions within a particular
muscle. Three major fibre types can be identified on the basis of the intracellular content
of myosin heavy chain isoforms (Staron and Johnson, 1993). These fibres can be
15
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distinguished with the use of staining techniques revealing the sensitivity of the
myofibrillar myosin ATPase enzyme exposed to various pH conditions (Brooke and
Kaiser, 1970). Type I are also called slow twitch (ST) fibres. Their metabolism is also
specifically adapted to prevent fatigue. For example Type I fibres have a high content of
myoglobin (an oxygen-storing protein) and enzymes that favour aerobic energy
production. The other major type of muscle fibre that has a lower aerobic capacity but a
high anaerobic capacity is known as a Type II, or fast twitch (FT), fibre. Sub-categories
of Type II fibers can also be found (e.g. IIA, lIB) (Simoneau, 1995). This fibre is
normally found in high percentages in sprint and power athletes.
Is there a correlation between the percentage fibre type and myosin heavy chain content
in human skeletal muscle? Using histochemical methods, Brooke and Kaiser, (1970),
delineated three major fibre types (I, IIA and lIB) in adult human skeletal muscle based
on the different pH sensitivities of their myosin adenosine triphosphatase (mATPase)
activity. More recently, Perrie and Bumford, (1986), electrophoretically separated three
myosin heavy chains (MHC I, MHC lIa and MHC lIb) in various human limb muscles,
the expression of which in single fibres has been found to correlate with various
mATPase-based fibre types (Staron et al., 1991). However, this nomenclature should be
altered to: I, IIA and IIX, since the so-called human lIB fibres actually express an MHC
isoform equivalent to that of the rat IIX and not to that of the rat lIB (Smerdu et al., 1994;
Ennion et al., 1995). Thus, after the discovery of a third fast isoform, the MHC IIX, it
has gradually become evident that the human fast fibres named "lID", according to
evaluation by ATPase histochemistry, contained a transcript much more similar to that of
rat IIX than of the rat lIB (Smerdu et al., 1994; Ennion et al., 1995). This lead to the
suggestion that the human MHC isoforms should be termed I, Ha and Ilx, to form
consensus with the nomenclature for the rat MHC isoforms (Schiaffino and Reggiani,
1994). To distinguish between fibre type and MHC isoform, it has been suggested that
fibre types should be called I, HA and IIX, whilst MHC isoforms should be termed I, Ha
and Ilx (reviewed by Myburgh 1994).
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In a study by Fry et al., (1994), the authors determined the degree of association between
the MHC content and the percentage area of major fibre types (types I, HA and HX) in
the vastus lateralis muscle from men and woman, and assessed whether training has an
effect on the relationship between these two variables. Their results showed that the
vastus lateralis muscle in the human contains various mixtures of three MHC's.
Endurance training caused a significant decrease in the percentage area of type HX after 4
weeks and a significant increase in the percentage area of type HA after 6 weeks for both
men and woman. Similar changes were also found for the MHC content. MHC HX
significantly decreased after only 2 weeks and MHC Ha increased after 4-weeks. No
changes in either percentage fiber type area or MHC content were found over time for the
control men and women. Because various types of high intensity training cause fibre type
transformations, a greater number of these fibres may occur as hybrid that are "caught in
transition" and hence cause an under or over estimation of the amount of change when
the change is determined by histochemistry rather than electrophoresis (Staron et al,
1991).
Thus, histochemical and electrophoretic techniques applied to human skeletal muscle
establish a relationship between the percentage fibre type area and the MHC content.
Because of the extensive use of mATPase histochemistry to distinguish skeletal muscle
fibre types the use of this method makes comparison with other studies easier. However,
since simple fibre typing (percentage calculation) does not take fibre area into account,
electrophoresis may provide a more accurate assessment of muscle fibre type
composition, especially in the absence of the equipment and software required for the
determination of fibre areas. Moreover, muscle samples that contain large numbers of
fibres coexpressing two MHC's in varying proportions (e.g. trained muscle) is definitely
more accurately analyzed by gel electrophoresis.
2.3.2Muscle fibre composition and cycling
Do cyclists need a specific muscle fibre type ratio? For a sprinter it would be ideal to
have a high percentage of Type HA or Type HB. It is difficult to determine an ideal fibre
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type for criterium riders, time trialists and road racers. For example, thanks to drafting a
cyclist with a good aerobic capacity (75 ml/kg/min) and a low percentage of Type I fibres
(40%) can keep pace with trained road cyclists.
Table 2.3.2: Speculates as to what may be the ideal fibre type ratios for various
disciplines within the sport of cycling.
Event & performance Type I fibre Type II fibre V02max
time % % ml/kg/min
Kilometer 25 75 55
1000 meters: 1min 6sec
Criterium specialist * 50 50 72
50 miles: 2 hours
Criterium specialist ** 65 35 75
50 miles: 2 hours
Stage racer 60 40 80
120 miles: 4hrs, 30min
Time trialist 70 30 75
25 miles: 58 minutes
(Table adapted from, Inside the cyclist: Physiology for the two-wheeled athlete, Burke et
al., 1984)
* Excellent sprinter ** Poor sprinter
Work completed by Coyle et al., (1992), found that besides needing a high maximal
oxygen consumption for success, elite road cyclists needed to possess a higher percentage
of Type I fibres and a greater amount of capillaries supplying oxygen. They also
concluded that cyclists with a high percentage of Type I fibres have a distinct advantage
than those with a high maximal oxygen consumption and higher percentage of Type II
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fibres. These conclusions were drawn by relating muscle characteristics to a 40-kilometer
time-trial performance that correlated highly with average power output during a l-hour
laboratory test. However, for shorter distances, such as a 5 km time trial, the demands for
fatigue resistance, power and speed are different. No data are available on the best fibre
composition for shorter distances with multiple demands.
Is a cyclist born with a certain fibre type ratio, or can it be changed with training? One
purpose of training is to develop and improve the metabolic capacities of muscle fibres.
There is much evidence to show alterations in metabolic characteristics of skeletal muscle
fibres, for example oxidative enzyme capacity (Simoneau, 1995). Although it has been
debated as to whether skeletal muscle fibre type distribution, particularly the proportion
of the Type I fibres, can be altered in response to several weeks of exercise training in
humans (Simoneau, 1995). Two different points of view are expressed in the literature.
The first one is that the percentage of Type I fibres is genetically determined and the
second is that it can be significantly modified in response to exercise training. Some
studies have shown no Type I modification in response to exercise training (Basset,
1994). The problem with these studies are, that they are done on a small number of
subjects. Nine out of the 12 longitudinal studies were done on 10 subjects or less. Three
studies, did however show significant alterations in the proportion of type I fibres. They
showed that several weeks of high intensity endurance (Howald et al., 1985) or
intermittent (Simoneau et al., 1985) exercise training increased the proportion of Type I
fibres.
The subtypes of Type II do show more consistent modification to training. With training,
Type IIX fibres can take on the characteristics of Type IIA fibres. This suggests that
through training these fibres can change their metabolic capacity and gain endurance
capacity. These changes are not only seen by qualitative histochemical analyses but also
when muscle samples are analyzed biochemically for MHC composition (Staron and
Johnson, 1993). Therefore, not only can metabolic capacity be altered, but also
contractile properties related to myosin ATPase activity. The increase in proportion of
fibres exhibiting more than one MHC isoform is also considered as another sign of fibre
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transformation in response to training (Staron and Johnson, 1993). Therefore, genetic
factors, for the most part, determine your muscle fibre type. You are born with a certain
percentage, but can change this a little with age or training (Simoneau and Bouchard,
1995).
The above physiological parameters can be objectively and exactly determined and can
therefore be used to predict performance. An understanding of muscle metabolism,
however, can also provide the cyclist with important knowledge. Even if it cannot always
be quantified in a way that can predict performance, this knowledge may influence
training regimen and nutritional interventions.
20
Stellenbosch University http://scholar.sun.ac.za
CHAPTER 3: The Energy Systems
" Those who are enamoured with the practice without the science, are like a pilot who
goes into a ship without a rudder or compass and never has any certainty of where he
is going."
-Leonardo Da Vinci-
The term energy systems is used to refer to a physiological entity that produces ATP to
sustain cellular processes, including muscle contraction (Hawley and Hopkins, 1995). As
the research project was conducted on cyclists, the question arises, how do muscles
produce the energy needed to ride a bicycle? On the surface it may seem simple: breathe
in oxygen and transport it to the working muscle, where it combines with food fuels and
the muscles contract to produce force. But it is not that simple. This section will provide
an integrated synthesis of traditional biochemistry, physiology, exercise physiology
textbook knowledge, as well as the refinements and details provided by current reviews
and recent experimental data.
The metabolic processes that supply the energy needs of muscle contraction usually take
place in the presence of adequate O2 to oxidize the carbohydrate sources of energy
completely to C02 and H20. This constitutes aerobic muscle activity. However energy
for exercise that is intense and where exhaustion sets in within one minute or less must be
supplied largely by anaerobic processes, because aerobic processes cannot supply energy
fast enough to supply such a demand (De Vries and Housh, 1994). Thus, the energy
needed for muscular contraction is produced by three independent systems: the
phosphagen, anaerobic (oxygen independent) glycolytic and aerobic (oxygen dependent)
systems (Ástrand et al., 1970; Gollnick, 1985). The first two systems are functions of
anaerobic metabolism and the third is obviously a function of aerobic metabolism. The
phosphagen system uses intracellular stores of adenosine tri-phosphate (ATP) and
creatine phosphate (CP) to provide the energy needed for maximal bouts of strength or
speed that last for a few seconds (Gaitanos et al., 1993). For high intensity exercise of up
to one minute in duration, energy is provided mostly by the anaerobic glycolytic system,
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which breaks down muscle glycogen without consuming oxygen (Hawley and Hopkins,
1995). Exercise lasting longer than one minute is powered mostly by energy provided by
the aerobic system, which uses oxygen in the breakdown of carbohydrates (glycogen and
glucose), lipids (triglycerides, fatty acids and ketones) and to a small extent, amino acids
(Hawley and Hopkins, 1995). To get a clearer understanding of how the different systems
function and inter-relate, each system will be first looked at as a separate entity.
3.1 The Phosphagen system.
In this system two high-energy phosphate compounds, adenosine triphosphate (ATP) and
creatine phosphate (CP) are used to store energy. During muscle contractions the stores
of ATP are broken down to produce free energy and the following metabolites:
ATP ~ATPase~ ADP + Pj+H+
The primary source of energy for muscle contraction is ATP. The ATP molecule allows
chemically bound energy to be converted to kinetic energy. The energy is released when
ATP is hydrolyzed to adenosine diphosphate (ADP) and inorganic phosphate (Pj ) at the
crossbridges of the myofibrillar proteins known as the actomyosin complex (Geeves,
1991). The liberated energy permits the cross-bridges from the myosin molecules to slide
over the thinner actin filaments. ATP is also involved in the restoration of a low
intracellular calcium concentration (sarcoplasmic reticulum ATPase) and the resting
membrane potential (Na+-K+ATPase) during relaxation before a subsequent activation of
the same fibre is possible (Vandervoort et al., 1983). However, the ATP stores can be
depleted very quickly and therefore the compound CP is brought into play almost
immediately and before ATP can be depleted. It undergoes a reversible reaction to release
the following:
CP +ADP +H+ f---CPK~ ATP + Creatine, (CPK is creatine phosphate kinase)
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Therefore the high-energy phosphate from CP can combine with ADP to resynthesize
ATP and muscle contraction can continue. The main reason this reaction is activated is to
buffer the rapid accumulation of ADP, resulting from ATP hydrolysis in the multitude of
energy requiring processes of muscle contraction and relaxation, in order to maintain an
optimal ATP:ADP ratio such that contraction can continue. The momentary rise in ADP
concentration is the primary stimulus to CP hydrolysis via the creatine kinase reaction.
The CP reservoir is relatively large compared with that of ATP and amounts to 70-80
mmol.kg' dry mass at rest (Spriet, 1995). Margaria et al., (1969) proposed that CP
degradation was the immediate and only substrate for ATP resynthesis during the early
stages « 10 sec) of intense exercise. Upon depletion of this substrate, glycogenolysis is
activated to provide a continued ATP supply via glycolysis.
For many years this "serial mobilization" theory of anaerobic ATP provision was used to
explain how human skeletal muscle responded to the large demand for ATP during high-
intensity exercise (Spriet, 1995). Evidence since that time has shown that CP degradation
is instantaneous at the onset of exercise and this was proven with biopsies taken
following less than 10 seconds of sprint cycling. It was shown that CP concentration fell
to approximately 50% of resting values and glycolytic intermediates increased up to 30
fold, thus rapid CP degradation was confirmed (Jones et al., 1985). The CP store is thus a
powerful energy buffer, as small changes in ATP and ADP concentrations ensure rapid
ATP resynthesis.
In a study by Spriet et al., (1987), they electrically stimulated the quadriceps femoris
muscles of seven males under extended anaerobic conditions to quantitate anaerobic
energy release and the contribution of the glycolytic system to total ATP production.
Glycolysis was responsible for 90 % of the total ATP production. Approximately 90, 55
and 50 mmolof ATPlkg dry muscle was produced during the initial three 16-contraction
periods, respectively. During the final 16 contractions only 15 mmolof ATP was
regenerated through glycolysis, therefore glycolysis was highest in the first contraction.
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There is more experimental evidence that does not support the view that anaerobic
glycolysis is only activated when CP stores are depleted in maximally contracting
muscle. Findings by Jacobs et al., (1983), evaluated the extent of anaerobic
glycogenolysis, as indicated by intramuscular lactate concentration, after 10 and 30
seconds of supramaximal exercise. They proposed that anaerobic glycolysis commenced
with the onset of muscular contraction, as lactate accumulated to 46.1 and 25.2 mmol/kg
dry muscle following 10 seconds of maximal cycling in males and females respectively.
Large accumulations were reported (19-61 rnrnol/kg dry mass) following only 6 and 10
seconds of cycling at high power outputs (Jones et al., 1985). The CP degradation in this
study demonstrated that CP stores had only depleted to approximately 25-33 % of the
resting content, which thus suggested that CP degradation and anaerobic glycolysis were
activated simultaneously at the onset of high-intensity activity.
To put the phosphagen energy system into a cycling perspective, the first few seconds of
high-intensity work, e.g. intervals, sprints and racing starts will certainly be the best
stimulus for this system. The quickness and explosiveness of the cyclists are also
determined by other factors such as muscle-fibre type (discussed in section 3.3.1)
3.2 The Anaerobic Glycolytic System.
The other anaerobic system is the glycolytic system. lts name is derived from the
pathway that can produce ATP from the utilization of carbohydrates without the use of
oxygen (also known as glycolysis), in particular the glycogen reserves in the working
muscle (Green, 1997). One of the end products of glycolysis is lactate. This system is
responsible for most of the energy generated in maximal efforts lasting from 10-15
seconds up to l-minute (Hawley and Hopkins, 1995).
The continuous demand for energy in this system requires that ATP be anaerobically
resynthesized as follows:
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Glucose + 602 + 38ADP + 38Pi ----7 6C02 + 6H20 + 38ATP
For this reaction to occur successfully, glucose has to be transported into the muscle. A
specific transporter protein (GLUT 4) is involved in the passage of glucose molecules
across the cell membrane of muscle tissue. Once the glucose molecule is inside the cell,
the first step of glycolysis is an irreversible phosphorylation to prevent loss of this
valuable nutrient from the cell: glucose is converted to glucose-ó-phosphate (G6-P) with
the aid of the enzyme hexokinase. The hexokinase reaction is an energy consuming
reaction, requiring the investment of one molecule of ATP per molecule of glucose.
There are two sources of carbohydrate substrate for this pathway, extracellular glucose
and intracellular glycogen. If glycogen, rather than blood glucose, is the substrate for
glycolysis, the first step is to split off a single glucose molecule. This is achieved by the
enzyme glycogen phosphorylase and the products are glucose l-phosphate (GI-P) and a
glycogen molecule that is one glucose residue shorter than the original. GI-P is then
rapidly converted to G6-P by the enzyme phosphoglucomutase, which then proceeds
down the glycolytic pathway. There is no breakdown of ATP in this first reaction. The
pathway continues and glycogenolysis and glycolysis require more input of ATP. This
occurs at the step where fructose 6-phosphate (F6-P) is converted to 1,6-diphosphate
(FDP) by the enzyme phophosfructokinase (PFK). PFK plays an important role in
controlling flux through the pathway. So far, glycolysis, which is intended to make
energy available to the cells, has required the investment of two ATP molecules, with no
immediate return.
Glycolysis effectively converts a 6-carbon glucose molecule to two 3-carbon molecules,
glyceraldehyde 3-phosphate and dihydroxyacteone phosphate. Each of the following
steps in glycolysis can thus be considered to occur in duplicate. Glyceraldehyde 3-
phosphate is then converted to 1,3-diphosphoglyceric acid that receives its additional
phosphate group from inorganic phosphate, so there is no further input of ATP. In the
next step however, ATP is formed and 1,3-DPG is converted to 3-phosphoglycerate. The
pathway continues until phosphoenolpyruvate (PEP) is formed. The last step in glycolysis
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then occurs and results in the transfer of the phosphate group from PEP to ADP and the
resulting formation of ATP and pyruvate. Thus the net effect of glycolysis can be seen to
be the conversion of one molecule of glucose to two molecules of pyruvate and net
formation of two molecules of ATP. If glycogen, rather than glucose is the starting point,
net three molecules of ATP are produced. Pyruvate can now go in two directions:
reduction of pyruvate to lactate in the absence of oxygen or pyruvate may undergo
oxidative metabolism to C02 and water and thus the onset of aerobic metabolism. Thus
'the end product of aerobic glycolysis is pyruvate, while the end product of anaerobic
glycolysis is lactate.
Lactate can accumulate within the muscle cells and reach concentrations higher than any
of the glycolytic intermediates. Lactate will begin to diffuse into the extracellular space
and eventually will begin to accumulate in the blood. Lactate together with hydrogen ions
leave the muscle cell and has the effect of making the buffer capacity of the extracellular
space available to handle some of the hydrogen ions that would cause intracellular pH to
fall and impair exercise performance in at least two ways. First, an increase in the
hydrogen ion concentration reduces the muscles' ability to produce ATP by inhibiting
key enzymes involved in both anaerobic and aerobic production of ATP. Second,
hydrogen ions compete with calcium ions for binding sites on troponin, thereby hindering
the contractile process (De Vries and Housh, 1994). Muscle pH at rest is approximately
7.1 but can decrease to 6.5 or less during high-intensity exercise due to the large
production of lactate (Maughan et al., 1997). At pH 6.5 the contractile mechanism of
muscle begins to fail and there is inhibition of some of the enzyme functions. Although
this does occur, the energy made available by anaerobic glycolysis allows the
performance of high-intensity exercise that would otherwise be impossible (Maughan et
al., 1997).
When lactate accumulates within the muscle cell it can reach high concentrations of
hydrogen ions, which leads to the burning sensation that cyclists experience in their
quadriceps when climbing a steep hill or going for an all out final sprint. The associated
accumulation of hydrogen ions results in a low pH, which stimulates the nerve endings in
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the muscle and results in the perception of pain. Lactate is discussed again in section 4.1
with references to exercise studies.
One energy system that is often overlooked, even by modem exercise physiologists, is
the purine nucleotide cycle (PNC) as ADP accumulation is also a factor in fatigue (Cooke
et al., 1988). Exercise of a high intensity may cause large decreases in the ATP
concentrations of the skeletal muscle (Cheetham et al, 1986). Simultaneously, an
increased production of ADP activates adenylate kinase, which together with AMP
deaminase maintains the balance of the adenine nucleotide pool, the ATP:ADP ratio.
2ADP ~K~ ATP +AMP (AK is adenylate kinase)
AMP + H+~ AMP deaminase~ IMP +NHt-,
where AMP is adenosine 5' -monophosphate and IMP is inosine monophosphate.
Skeletal muscle adenine nucleotide loss can occur in two ways during exercise:
1. Deamination of AMP to IMP and ammonia catalyzed by AMP-deaminase. A large
amount of IMP can be formed in this way, especially if the demand for ATP is larger
than the capacity to rephosphorylate ADP
2. There is also the dephosphorylation of AMP to adenosine, catalyzed by 5'-
nucleotidase.
Inosine-5' -monophosphate (IMP) and adenosine can further be degraded to inosine,
xanthine and hypoxanthine.
Muscle does not possess the enzyme required to convert hypoxanthine to inosine and
therefore, once formed hypoxanthine tends to leave the muscle and is eventually
converted to uric acid in the liver and is eventually excreted by the kidneys. Alternatively
IMP can be converted to adenylo-succinate, thus the deamination of AMP to IMP and the
subsequent reamination of IMP to AMP constitute the completion of the purine
27
Stellenbosch University http://scholar.sun.ac.za
nucleotide cycle. But adenylo-succinate occurs in low concentrations after muscle
fatigue, which is a sign that the adenylo-succinase activity is inhibited during exercise.
3.3The Aerobic System
As discussed earlier, the aerobic system generates ATP from the oxidative breakdown of
fuels, like carbohydrates, lipids and some amino acids. Exercise lasting longer than one-
minute is usually powered predominantly by the aerobic system (Hawley and Hopkins,
1995). However, it is a misconception that neither CP nor anaerobic glycolysis are any
longer operative. To prove this Withers et al., (1991) showed that aerobic metabolism
was estimated to comprise 28, 49 and 64 % of the overall energy release for 30, 60 and
90 seconds of maximal cycling. So when high intensity exercise was extended to 90
seconds, anaerobic metabolism contributed 36-54 % of the required energy and aerobic
contribution was 46-64 % (Serresse et al., 1988; Withers et al., 1991). This shows that
CP and anaerobic glycolysis are still functioning, be it a smaller percentage than at the
onset of the exercise, together with the aerobic system.
As discussed earlier glucose becomes available as an energy substrate either by
glycogenolysis of glycogen stored in the muscle fiber or by the transportation of blood
glucose into the muscle fibre. Glycolysis proceeds until two molecules of pyruvate are
formed. In the anaerobic glycolytic system the reaction proceeds from here with the
formation of lactate. In the presence of sufficient oxygen the pyruvate is able to enter the
mitochondria and proceeds through a metabolic course known as the Krebs cycle (De
Vries and Housh, 1994).
The Krebs cycle equation is as follows:
acetyl-CoA + ADP + 3NAD++FAD ~ 2C02 + ATP + 3NADH + 3H++ FADH2 CoA
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The two pyruvate molecules must now be converted into two molecules of acetyl
coenzyme A (acetyl-CoA). Acetyl-CoA, the major fuel for the Krebs cycle in the
mitochondrion, combines with the oxaloacetate to become citrate, a 6-carbon tri-
carboxylic acid catalysed by the enzyme citrate synthase. Citrate is then converted to its
isomer, isocitrate that undergoes further oxidative decarboxylation to a-ketoglutarate.
During this reaction a molecule of CO2 is released and the first of 3 nicotinamide adenine
dinucleotide (NAD+) in its reduced form NADH molecules are released. Another
molecule of CO2 is released and another molecule of NADH is formed as a-ketoglutarate
is converted to succinyl-CoA. The energy released from the breaking of the C-S bond of
succinyl-CoA is used to phosphorylate guanosine diphosphate (GDP), thus forming
guanosine triphosphate (GTP) and succinate. An enzyme called nucleotide diphosphate
group kinase catalyses the production of ATP from GTP. Succinate is then oxidised to
fumarate and the co-enzyme flavin-adenine dinucleotide (FAD), rather than NAD+ is
reduced to FADH2• Fumarate goes on to be converted to malate by the enzyme fumarase.
Finally oxaloactate is formed once again from malate with the reduction of NAD+ to
NADH. In one complete cycle, 1 molecule of ATP, 3 molecules of NADH and 1
molecule of FADH2 are formed.
Hawley and Hopkins, (1995), proposed that the oxidation of carbohydrates and lipids
should be regarded as two functionally distinct aerobic power systems: the aerobic
glycolytic system (which oxidizes carbohydrate for high-intensity endurance events) and
the aerobic lipolytic system (which oxidizes lipids to provide a large amount of the
energy for longer, less intense endurance and ultra-endurance activities). An advantage of
this new view is that dietary and training regimens could be tailor made for either a high-
intensity endurance activity or an ultra-endurance event.
The only difference between the two types of aerobic systems is that, in the breakdown
and oxidation of lipids, a set of cytoplasmic and membrane-bound enzymes is responsible
for the ~-oxidation of lipids to fatty-acyl co-enzyme A (CoA), the transport of fatty-acyl
CoA into the mitochondria and its conversion to acetyl-CoA. Separate sets of enzymes
control the conversion of intra-and extramuscular carbohydrate to pyruvate and then to
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acetyl-Coá. Thereafter the pathways for the oxidation of the acetyl moieties from either
lipids or carbohydrates are the same (Hawley and Hopkins, 1995).
So what makes these two aerobic systems distinct? With regards to training they are
distinctly different. For example, activities that engage the anaerobic glycolytic pathway
(AnGP) also engage either phosphagen or aerobic glycolytic power systems. But
activities that are short and intense «30 sec) only use phosphagen and AnGP and do not
result in maximal oxygen consumption or adaptation thereof (Jenkins et al., 1994a;
Linossier et al., 1993).
Hargreaves et al., (1991), reported no sparing of muscle glycogen in humans after one-
legged knee extension exercise for 1 hour after 30 minutes of an infusion of a fat
emulsion and heparin, which was also administered during exercise. In a study by
Vukovich et al., (1993), they wanted to determine whether saturated or unsaturated fatty
acids affected muscle glycogenolysis to varying degrees in cycling exercise. Their results
confirmed that increasing FFA will spare glycogen during exercise at 70 % of V02max
on a cycle ergometer. The magnitude of the sparing was not related to the increase in the
FFA above the control trial levels and the sparing appeared to be dependent on the
saturation of FFA.
Brooks and Mercier, (1994), proposed the "crossover" concept. According to this concept
endurance training results in muscular biochemical adaptations that enhance lipid
oxidation as well as decrease the sympathetic nervous system (SNS) response to a given
submaximal exercise stress. These adaptations promote lipid oxidation during mild- to
moderate intensity exercise. In contrast, increases in exercise intensity are perceived to
increase contraction-induced muscle glycogenolysis, change of the fibre type recruitment
and increase the activity of the SNS. Substrate utilization in an individual at any point in
time depends on the interaction between exercise intensity-induced responses (which
increase carbohydrate utilization) and endurance training-induced responses (which
promote lipid oxidation). Thus, the "crossover" concept represents a theoretical means by
which one can understand the effects of exercise intensity and prior endurance training on
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the balance of carbohydrate and lipid metabolism during sustained exercise. It may also
explain and reconcile seemingly divergent results in the literature concerning the balance
of carbohydrate and lipid metabolism during exercise (Brooks and Mercier, 1994). Thus,
it can once again be said that no one energy system operates entirely by itself during
exercise as is shown in the following table:
Table 3.3.1: The relationship between various cycling events and energy systems
Event Performance Phosphagen Anaerobic Aerobic
Time System (%) System System
(%) (%)
Hours and Min
100-mile road race 3:55-4:10 - 5 95
lOOKcriterium 2:05-2:15 5 10 85
lOOKteam time trial 2:10-2:20 - 15 85
25-mile time trial 0:52-0:60 - 10 90
25-mile criterium 0:50-0:60 5 15 80
Min and Sec
lO-mile points race (track) 20:00-25:00 10 20 70
4000m individual pursuit 4:45-5:05 20 55 25
Kilometer 1:07-1: 13 80 15 5
Match sprints 0:11-0:13 98 2 -
From: "The physiology of Cycling" by E. Burke. In Science of Cycling (p.2) by E.R.
Burke (Ed.), 1986, Champaign, IL: Human Kinetics.
For the sprinters the most important energy source is the phosphagen system. The
kilometer cyclists and the pursuiters, immediately use high-energy sources but quickly
activate and obtain additional energy from the anaerobic breakdown of carbohydrates.
The long-distance cyclists rely on the aerobic breakdown of carbohydrates and lipids for
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energy. The energy systems are thus linked to the particular distance, time and intensity
at which the cyclists perform.
3.4 The Energy Systems and Short Duration, High Intensity Cycling.
Depending on the duration and intensity of the exercise bout, some or all of the energy
systems may be in operation at one time. During submaximal (steady state) exercise,
ATP resynthesis can be maintained by the oxidative combustion of fat and carbohydrate
stores. However, during high-intensity (non-steady state) exercise the relatively slow
activation and rate of energy delivery of oxidative phosphorylation cannot always meet
the energy requirements of contraction.
Non-steady state exercise can be sustained for durations in excess of 5 minutes before
fatigue is evident (Maughan et al., 1997). The subjects in my research project completed
a number of 5km cycling time trials. Half of the 5km time trials had a pre-time trial
stochastic cycling test (32 min long) training intervention that consisted of submaximal
steady state workloads. These workloads were interspersed by shorter time periods at
either low intensities or supramaximal intensities. Under these conditions substrate
oxidation can make the most significant contribution to ATP production.
The durations of the 5km time trials were approximately 7-8 minutes. Oxidative
phosphorylation can contribute as much as 80 % of the total energy yield for this cycling
exercise as it is summarised in the underlying table and thus indicates the importance of
substrate oxidation during high intensity exercise.
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Table 3.4.1: The energy yield required for cycling.
Exercise Time/maximal effort
Energy Source lOsec Imin 2min 4min 10min 30min 60min
Anaerobic 85 65-70 50 30 10-15 5 2
Aerobic 15 30-35 50 70 85-90 95 98
From: "The physiology of Cycling" by E. Burke. In Science of Cycling (p.3) by E.R.
Burke (Ed.), 1986, Champaign, IL: Human Kinetics.
Under these conditions muscle glycogen would be the principal fuel used, since muscle
glucose uptake is inhibited by glucose 6-phosphate accumulation and adipose tissue
lipolysis is inhibited by lactate accumulation. The rate of muscle glycogen utilization
during 4 minutes of fatiguing high intensity exercise is approximately 45 mmol.kg.dm"
(Spriet et al., 1995) which is considerably lower than the rate of approximately 160
mmol.kg.dm' observed during 30 seconds of maximal sprinting (Karlsson and Saltin,
1970). This glycogen utilisation can be divided into anaerobic utilisation or full
oxidation. Full oxidation of carbohydrate provides far more ATP than anaerobic
breakdown, even if the quantity of glycogen utilized is less. However, even assuming that
only 50 % of the glycogen in the former example is oxidised, it can be calculated that the
net amount of ATP generated by glycogen oxidation will be about 2 fold greater than that
generated by anaerobic glycogen degradation to lactate during 30 sec of maximal
sprinting (Maughan et al., 1997).
When the exercise is repeated over several bouts, as is the case with the stochastic
cycling test, interspersed with short rest periods, the rates of muscle CP hydrolysis and
lactate accumulation may be different in each bout compared with the first bout which
was started with the subject in a completely rested state. The rates decline substantially.
The progressive fall in CP utilization is likely to be related to the extent of CP resynthesis
between exercise bouts i.e. if recovery is insufficient to enable complete CP resynthesis
to occur, this will limit anaerobic ATP resynthesis during a subsequent bout of exercise
(Maugan et al., 1997).
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Substrate use can be determined experimentally. The respiratory exchange ratio (RER)
during steady state conditions can give a reasonable estimate of the proportions of
carbohydrate and lipid being oxidised. An RER of 1.0 indicates that only carbohydrates
are being oxidised, whereas an RER of 0.7 indicates that fat is the substrate being
oxidised. In the exercising athlete this can be different if ventilatory compensation has
already occurred following buffering of hydrogen ions. Ventilatory threshold can be
reached before and RER of 1 and this will affect interpretation of RER. With the methods
used in my thesis, the respiratory exchange ratio (RER) can only provide information of
oxidized fuels, but not anaerobic fuel utilization. This can be determined directly from
muscle biopsies before and immediately after exercise, or indirectly from the
accumulation of byproducts. Muscle biopsy samples were also taken to determine the
depletion of high-energy phosphates as a result of the high intensity exercise protocol.
The muscle biopsies were used to determine the accumulation of intramuscular energy
reserves due to in vivo dietary manipulations.
3.5Nutritional intervention
For the successful completion of any physical task, chemical energy must be converted to
mechanical energy at rates appropriate to the muscles need. As discussed in previous
sections, to meet the requirements, the body has evolved in various ways to fuel itself.
During the last 150 years a large number of studies were performed to determine the
utilization of different foodstuffs as energy sources during exercise and to determine
nutritional effects on exercise performance. Results obtained and opinions claimed have
varied through the years and can be summarized according to Hultman, (1989):
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Table 3.5.1: Early studies on sources of energy used for exercise.
Studies Result
Von Liebig (1842) Suggested that protein was the main source of energy
Pettenkoffer and Voit Observed that the urinary output of urea was unchanged
(1896) during exercise and concluded that protein was not an
important substrate during exercise.
Zuntz (1896) Showed that both fat and carbohydrates could be utilized.
Chauveau (1896) Maintained that carbohydrate was the sole energy source.
Krogh and Linhardt Made direct estimations of carbohydrate and fat utilization
(1920) & Christensen during exercise by measuring RER. They also showed
and Hansen (1939) nutritional effects both on metabolic processes and on
endurance capacity during prolonged exercise.
Later studies used radio-labeled glucose (Reichard et al., 1961) which demonstrated that
skeletal muscle glucose uptake increased during exercise. The reintroduction of the
muscle biopsy technique in the 1960's confirmed the importance of muscle glycogen
availability for exercise performance and established the theoretical basis for glycogen
loading (Bergstrom et al., 1967). The importance of the availability of muscle glycogen
and blood glucose during prolonged exercise is demonstrated by the observation that
fatigue is often associated with muscle glycogen depletion or hypoglycemia and thus
reduced pyruvate levels (Sahlin et al., 1990).
The role of the diet in optimizing the glycogen stores in skeletal muscle and the
subsequent exercise performance was confirmed in a study by Costill, (1988). The
exercise and diet regimen has been referred to as glycogen super-compensation or
carbohydrate loading and consists essentially of a glycogen depleting exercise followed
by 3-4 days with a high carbohydrate intake. The study by Rauch et al., (1995), also
compared the effects of supplementing normal diets with additional carbohydrate, in the
form of potato starch. Increasing the carbohydrate intake by approximately 72 % for 3
days prior to the trial elevated the pre-exercise muscle glycogen contents, improved
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power output and extended the cycling distance covered in l-hour. They were also able to
show that muscle glycogen contents were similar at the end of the 3 hour trial, indicating
a greater utilization of glycogen when subjects were carbohydrate loaded, which may be
responsible for their improved cycling performance.
In another study, Jenkins et al., (1994), examined whether a pre-exercise consumption of
glucose by subjects having adhered to a 3 day low carbohydrate diet or normal
carbohydrate diet would influence supramaximal intermittent exercise performance. No
changes in performance were found but, the subjects that consumed the glucose solution
before the trial consumed significantly less oxygen during exercise than those who had
been given the placebo solution. Thomas and colleagues (1991) looked at the advantage
of carbohydrate supplementation for improved performance. They hypothesized that low
glycemic index (GI) foods may confer an advantage when eaten before prolonged
strenuous exercise by providing a slow release source of glucose to the blood without an
accompanying insulin surge. Their findings suggested that a low GI pre-exercise meal
may prolong endurance capacity, as endurance time after low GI was 20 min longer than
after the intake of high glycemic index food (P<0.05). The mechanism for the improved
performance is less post-prandial hyperglycemia and hyperinsulinemia, lower levels of
plasma lactate before and during exercise and by maintaining plasma glucose and FFA at
higher levels during critical periods of exercise.
Lipid fuel sources are important energy substrates for skeletal muscle metabolism during
endurance exercise. Their contribution is dependent on factors such as intensity and
duration of the exercise test as well as dietary and training status. In a study by Helge et
al., (1998), they evaluated the effect of duration of exercise on the interaction between
training and a fat-rich or carbohydrate-rich diet on endurance performance. Time to
exhaustion, when exercising at the same absolute workload, was similar in fat-rich
conditions and carbohydrate-rich groups and was significantly increased by 166% and
150% in fat-rich and carbohydrate-rich respectively, after 4-weeks. After 4-weeks RER
was significantly lower during exercise in the fat-rich diet groups both compared with the
initial test with the carbohydate-rich diet, while no changes were seen in the
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carbohydrate-rich diet group. Thus their findings showed that endurance performance
was enhanced similarly after both 2 and 4-weeks of adaptation to training and a fat-rich
or carbohydrate-rich diet.
Proteins and amino acids are often ignored in discussions of metabolism during exercise
probably for two reasons: firstly, amino acids contribute only a minor portion between 5-
10% (Brooks, 1987) of the energy consumed during exercise, although one must
recognise that even a minor contribution to the energy consumption is important in
conditions of high energy demands over a prolonged period of time; and secondly little is
known about this complex aspect of metabolism. Although it is important to mention that
the protein composition of muscle is critical to the character of the tissue, metabolism of
amino groups is very dynamic and may be critical to the overall regulation of metabolism
and numerous amino acid pathways directly involved in glycolytic or TCA intermediates
as either substrates or products (Graham et al., 1995). Thus, by incorporating amino acid
metabolism, better integration of the carbohydrate and fat metabolism can come to the
fore.
The ability of the skeletal muscle to utilise amino acids as an energy source has been
regarded as limited but certainly not insignificant. In a study by Maclean et al., (1991), it
was demonstrated that during prolonged exercise (2-3 hours) there was no net
accumulation of branched chain amino acids (BCAA) isoleucine, leucine and valine in
the plasma or in contracting muscle. This suggests that active muscle was responsible for
the removal and oxidation of any amino acids released into the plasma during exercise.
The question of what an athlete should eat in order to achieve superior performance must
be one of the oldest questions in sport history. Today we have a comprehensive
knowledge of essential nutrients and supplements required for maintaining good health.
However the exact nutritional requirements needed to perform varies from athlete to
athlete and sport to sport. As the research project was conducted on trained cyclists, the
frequently asked question of how can nutrition improve cycling performance, can be
asked. The main nutritional need of cyclists is an increased energy turnover. The need
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becomes greater the more intensive your cycling exercise and the longer your total
energy expenditure.
A study on cyclists in the Tour de France (Brouns et al., 1989), looked at the effect of
carbohydrate dietary manipulation during 2-days of long lasting exhausting cycling on
food and fluid intake, energy balance, nitrogen balance and nutrient oxidation. They
concluded that cyclists are able to maintain energy balance when energy expenditure
levels exceed 20 MJ by using concentrated carbohydrate solutions in addition to normal
carbohydrate-rich diet. In contrast, by using a normal carbohydrate-rich diet alone energy
balance cannot be maintained in such a situation. The ad libitum supply of 20% and 10%
carbohydrate solutions during cycling as was conducted did not impair fluid intake or
overall fluid status of the body compared with water intake. The intake of substantial
amounts of a carbohydrate solution during exercise causes an increased carbohydrate, a
decreased fat and a decreased protein oxidation compared to normal carbohydrate diet.
They finally deduced that the recommended level of protein intake for endurance athletes
performing highly intensive sustained exercise, consuming a carbohydrate-rich diet and
being in a positive energy balance, most probably is in the range of 1.5-1.8 g.kg' body
weight per day. Thus, nutritional choice can have an effect on performance in the range
of duration simulating 2 days of the Tour de France race. However, cycling of shorter
duration and higher intensity may require different nutritional intervention to optimize
performance.
A growing body of evidence is becoming available to indicate that dietary creatine (Cr)
maybe a necessary requirement for individuals wishing to optimize their ability to
perform high-intensity exercise. The nutritional intervention in the thesis research project
was that of creatine monohydrate supplementation for the active agent group and a
glucose polymer substitute for the placebo group. Despite the overwhelming
concentration of researchers on endurance exercise (Barnett et al., 1996; Godley and
Yates 1997), the advantages of creatine supplementation has shifted focus to shorter
duration and higher intensity exercise (Balsom et al., 1993; Kirksey et al., 1997; Prevost
38
Stellenbosch University http://scholar.sun.ac.za
et al., 1997) to optimize performance. Creatine is not a new phenomenon and is discussed
in great detail in Chapter 5.
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Chapter 4: Muscle metabolism.
4.1 Lactate
Lactate is the by-product of anaerobic energy production. Under these conditions,
glucose degradation stops at the 3-carbon lactate. The lactate so produced is released into
the blood stream and picked up by the liver, which converts the lactate back to glucose.
This glucose returns to the muscle for further glycolysis. Muscle lactate can also be
harnessed by the cardiac muscle or other skeletal muscles working at lower intensities,
that oxidizes it as a source of energy.
Can training alter blood lactate accumulation? It appears so. When the aerobic capacity of
the cyclist is increased with training, less lactate is produced at a certain workload than in
the untrained state at the same absolute workload (Brooks, 1986). This occurs because
the Krebs cycle is able to remove lactate's precursor, pyruvate at a sufficient rate to
prevent a large conversion to lactate. Despite the widespread use of blood and plasma
lactate concentrations in assessing performance, interpretation and application of changes
in lactate levels have shown considerable variation. The following is a table of six
commonly used lactate parameters:
40
Stellenbosch University http://scholar.sun.ac.za
Table 4.1: Commonly used lactate parameters.
Researcher Lactate Parameter
Yoshida et al., 1984 Lactate threshold (LT) (the power output at
which [plasma lactate] begins to increase
sharply above the resting level during an
incremental exercise test. Commonly used
by many researchers.
Thoden, 1991 LT 1 (the power output at which plasma
lactate increases by ImM or more
compared with the previous workload.
Cheng et al., 1992 LTD (the lactate threshold calculated by the
D-max method)
Cheng et al., 1992 LTMOD(the lactate threshold calculated by
a modified D-max method)
Kindermann et al., 1979 L4 (the power output at which plasma
lactate reaches a concentration of 4
mmol.L"
Beaver et al., 1985 LTLOG {the power output at which plasma
lactate concentration begins to increase
when the log[La] is plotted against the log
(power output) }
Irrespective of both the controversy surrounding the concept of the "lactate threshold"
and of arguments over nomenclature, lactate parameters have proven useful as
determinants of endurance performance. What is uncertain is which of the fore-
mentioned parameters best predict l-hour endurance performance. Bishop and colleagues
(1998) concluded that every lactate parameter calculated in their study was better
correlated with average power output during the l-hour cycle than was V02max. Of the
six parameters LTDwas the most highly correlated with one hour cycle performance (r =
0.84, P<O.OOl).
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Comparison of different studies should take into consideration differences in blood
sampling methods and/or exercise protocol. The choice of blood sampling site (arterial,
venous or capillary) and the choice of blood media analyzed (plasma, lysed or precipitate
whole blood) have been shown to influence the exercise intensity corresponding to a
fixed lactate concentration (Foxdal et al., 1991; Yoshida et al., 1982), but not to
significantly alter lactate threshold. Lactate concentrations and lactate parameters have
also been shown to be exercise protocol specific (Fry et al., 1992; Heck et al., 1985).
The question that still remains is why lactate parameters should provide a better predictor
of endurance performance than V02max? It could be that lactate parameters may be
related to a rate of energy expenditure at which muscle cell homeostasis is sufficiently
disturbed to stimulate glycogenolysis, resulting in accelerated glycogen utilization and
lactate production. The constantly strong relationship between endurance performance
and lactate parameters provides a simple method of estimating a rate of energy
expenditure, which will not prematurely deplete glycogen stores (Coggan and Coyle,
1991).
The simple measure of plasma lactate concentration is affected by lactate appearance rate
and lactate disappearance rate. Lactate disappearance (= removal/clearance) rate is
determined by both oxidation of lactate and utilization of lactate as a gluconeogenic
precursor. Reported patterns of lactate removal in humans suggest that a larger fraction
of the post exercise lactate load is removed gluconeogenically under some circumstances.
These circumstances were shown by Ástrand et al., (1986), who estimated a theoretical
maximum of 40% for lactate oxidation following brief intense exercise, whereas
replenishment of muscle glycogen was proposed as the fate of 50% of the post-exercise
lactate pool. Lactate removal across the splanchnic bed was estimated as only 10% of the
total. In contrast Bangsbo et al., (1991), estimated that only 13-27% of the lactate
removed in humans recovering from 3 minutes of intense leg exercise served as a
gluconeogenic substrate. Lactate irreversible disposal and oxidation rates were also
studied by Mazzeo et al., (1986), on subjects at rest, during easy exercise and during hard
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exercise. They concluded that lactate disposal rate is directly related to the metabolic rate,
oxidation is the major fate of lactate removal during exercise and that blood lactate
concentration is not an accurate indicator of lactate disposal and oxidation.
Bergman et al., (1999), evaluated the hypothesis that endurance training decreases
arterial lactate concentration during continuous exercise by decreasing net lactate release
and appearance rates and increasing metabolic clearance rate. They concluded that active
skeletal muscle is not solely responsible for elevated arterial lactate concentration and
training increases leg lactate clearance, decreases whole body and leg lactate production
at a given moderate-intensity power output and increases both whole body and leg lactate
clearance at a high relative power output.
A second important finding in the study by Bishop and colleagues (1998) was the strong
relationship between peak sustained power output (PSPO) and the one hour cycle
performance (r = 0.81, P<O.OOl).This is in agreement with previous research on cyclists
(Hawley and Noakes, 1992). It shows that PSPO is a better predictor of endurance
performance than V02max and similar to LTMoD(the lactate threshold calculated by a
modified D-max method). Thus cyclists who record both a high PSPO and have delayed
accumulation of lactate are likely to perform best. A question that remains to be answered
is the relative importance of PSPO vs. lactate parameters on performance in even shorter,
high intensity endurance events.
4.2 The Purine Nucleotide cycle
As indicated in section 2.2, it is suggested that adenine nucleotide loss occurs during
intense muscle contraction. Intense exercise to fatigue can lead to a 20% decrease in ATP
concentrations determined immediately after exercise. Of this decrease 65% can be
appointed to IMP formation, 14% to ADP and AMP increase and 2% to the formation of
inosine, that means that 18% of the purine that was in the cell before exercise, can not be
accounted for (Goodman and Lowenstein, 1977). This implies that it has left the muscle
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compartment in one or another form and is likely to be found in the form of one or more
metabolites in the blood compartment. During the initial stages of recovery the IMP
concentration decreases while [ammonia] remains constant. This decrease is due to the
reactions that lead to the formation of xanthine.
As discussed previously, the purines must move out of the muscle to account for the
decrease in purine levels in the muscle cell. During exercise the [hypoxanthine] increases
slightly in the blood. During the recovery phase it can increase l S-fold, with a peak
reached approximately 15 minutes after fatigue (Hellsten Westing et al., 1989). The
increase in plasma inosine levels is similar, but the peak concentration is reached
approximately 20-minutes after fatigue and then decreases sharply (Hellsten Westing et
al., 1989).
The appearance of hypoxanthine and inosine in the blood plasma is paired directly with a
net uptake of these molecules in the liver. This uptake takes place by means of diffusion
or facilitated diffusion. The appearance of hypoxanthine and inosine is also paired with
the release of urate and xanthine into the blood stream. This is an indication that these
two purines in the liver are irreversibly converted to urate and xanthine and thus making
the liver one of the main areas of urate synthesis. Inosine and hypoxanthine can however
be changed to IMP and AMP in the liver (Hellsten Westing et al., 1989), so not all is
converted and released as urate.
Skeletal muscle produces ammonia during short-term, intense exercise as well as
prolonged, sub-maximal exercise. It has already been suggested that ammonia produced
during both types of exercise originates from AMP-dearninase reaction of the nucleotide
cycle. However, amino acid catabolism can also produce ammonia and the oxidation of
branched chain amino acids (BCAA), isoleucine, leucine and valine increases in skeletal
muscle during long duration exercise (Hargreaves, 1991). During exercise of
approximately 40% V02max and greater, ammonia production increases proportionally
to intensity. At lower exercise intensities, the muscle ammonia release tends to balance
the clearance and little change in plasma ammonia is found. However, plasma and muscle
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ammonia concentrations rise rapidly during more intensive exercise because clearance
can not match ammonia release from active muscle. In healthy subjects, values of 100-
150 !..tM are typically observed at exhaustion after long duration exercise (Graham and
Mclean, 1992).
45
Stellenbosch University http://scholar.sun.ac.za
CHAPTER 5: Creatine
5.1 Historical Background
Despite the fact that athletes have only used creatine as an ergogenic aid for about a
decade, the "creatine time line" dates back a long way. The French scientist Michel-
Eugene Chevreul, who named it after the Greek word for flesh, discovered creatine (Cr)
in meat extracts in 1832. Due to detection problems, it was not until 1847 that Liebig was
able to confirm the presence of creatine as a regular constituent of meat (reviewed by
Demant and Rhodes, 1999). At this time Liebig also observed that the meat of wild foxes
that were killed in the chase had ten times the amount of creatine than those in captivity
and came to the conclusion that working of the muscle resulted in the increase and
accumulation of creatine. It was also at this time that two other researchers, Heintz and
Pettenkoffer, also discovered a substance in urine, creatinine (a byproduct of creatine
degradation), confirmed later by Liebig (reviewed by Balsom et al., 1994). The
concentration of creatinine in urine was directly related to muscle mass and therefore it
was speculated that the creatinine found in urine was derived directly from the creatine
stored in muscles.
Creatine research continued, but it was not until the beginning of the 20th century that it
was observed that not all the creatine that was ingested by animals and humans was
reclaimed in the urine, which suggested that the body was retaining some. In 1912 and
1914, Denis and Folin determined that the creatine content of cat muscle increased by
70% following creatine ingestion (reviewed by Demant and Rhodes, 1999). By 1923
Hahn and Meyer had estimated the total creatine content of a 70kg male to be around
140g (Needham, 1971). Thus, after only seven days of supplementation one could have
ingested an equal amount to the total body store.
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In 1927 and 1929, Fiske and Subbarow discovered a labile phosphorous in the resting
muscle of cat, which they named phosphocreatine or creatine phosphate (CP) (reviewed
by Balsom et al, 1994). Itwas shown that the concentrations of CP decreased for a period
of time during electrical stimulation of skeletal muscle, but then increased to previous
levels following a recovery period (Hunter, 1928). Due to the early work of these authors,
the identification of free creatine (Crfree) and CP forms have been recognised as key
intermediates of skeletal muscle metabolism. It is surprising, therefore, that attempts to
supplement in athletes took so many more decades to come about.
Through the re-introduction of the needle biopsy technique (Bergstrom, 1962) it was
possible to study the breakdown and resynthesis of adenosine triphosphate (ATP) and CP
in skeletal muscle, as well as to determine the role CP plays in skeletal muscle
metabolism during exercise (Hultman et al., 1967). More recently the role of Crphosin
skeletal muscle metabolism has been studied with nuclear magnetic resonance
spectroscopy (NMR) techniques (Kreis et al., 1999). Although studies with creatine
supplementation can be traced back to the end of the 19th century, it appears that only
recently has the influence of creatine supplementation on exercise performance in
humans been studied (reviewed by Balsom, et al., 1995).
It appears that the first documented use of Cr supplementation was with the British
athletes training for the 1992 Olympics in Barcelona. Creatine was credited with
powering several of the British athletes to gold medals. The London Times (August 7,
1992) reported that Linford Christie, lOO-meter gold medalist, trained with creatine
before the 1992 Olympics, it also reported that Colin Jackson, the champion British 110
meter hurdler, began taking creatine just before the Olympics. Although he did not win
the gold medal at the Olympics, he soon beat the Olympic gold medalist, Mark McCoy,
on several occasions. Shortly thereafter, U.S. champion athletes began using creatine
(Passwater, 1997). This indicates that the athletes were possibly ahead of the scientists in
the "creatine game".
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Articles in athletic magazines occasionally mention a rumour that USSR and Bulgarian
athletes may have been using creatine for many years, perhaps since the 1970's. No one
in the creatine field of research has found any documentation on this use.
Creatine supplements especially designed for performance and strength enhancement
were not commercially available until about 1993. In 1993, researchers Almada and Byrd
introduced their formulation based on reports in the scientific literature, plus their own
research. In late 1992 and early 1993, the results seemed so unbelievable that they had
little success convincing established companies to introduce Cr supplements in a
convenient form, which athletes could use to achieve Cr loading and maintenance. Thus
they formed their own company, which became incorporated in mid-1993 and introduced
the first commercial product especially designed to take advantage of their scientific
research. Since that time, nearly all the companies making sports nutrition supplements
have introduced kindred products (Passwater, 1997). This has thus made creatine widely
used and available and we can now scientifically attempt to determine who should be
using it and how as well as who is using it and wasting it.
5.2 Biosynthesis
5.2.1 Biochemistry
What is creatine? Creatine is an amino acid compound that can be endogenously
synthesized and creatine phosphate is an important reservoir of high-energy phosphate
groups in our muscles. Its chemical name is methyl guanidine-acetic acid. The structure
of creatine is
NH2 - C (NH) - NCH2(COOH) - CH3
The synthesis of creatine (as reviewed by Walker, 1979) involves 3 amino acids: glycine,
arginine and methionine. In the first step of biosynthesis, a portion of the amino acid
arginine is removed and added to the amino acid glycine to form a new compound called
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guanidinoacetic (GAA). The portion removed from arginine and transferred to glycine is
called an amidine group and its transfer is made possible by the enzyme glycine
transamidinase.
The second step involves removing a portion of a sulphur-containing compound called S-
adenosylmethionine (SAM). SAM is derived from the amino acid methionine. The
portion transferred from SAM is called a methyl group and its transfer to GAA is made
possible by the enzyme guanidinoacetate methyltransferase. After the methyl group has
been added to GAA, the resulting compound is called methyl guanidine acetic acid or
simply creatine. So it can be said that creatine is formed from parts of the 3 amino acids -
arginine, glycine and methionine - and it can also be said that they are precursors of
creatine (Walker, 1979).
One could thus ask if diets sufficient in arginine, glycine and methionine be good enough
supplements? Methionine is a dietary essential. It has many functions in the body and the
metabolic consequences of methionine deficiency are many and varied. Methionine has a
high intracellular turnover because it is involved in the initiation of peptide synthesis and
in a variety of trans-methylation and trans-sulfuration reactions (Storch et al., 1990).
Methionine may be the endogenous amino acid that is most limiting for maintenance of
body protein and nitrogen balance and for effective reutilization of other amino acids
(Storch et al., 1990). Since methionine is a nutritionally indispensable amino acid, its
continued availability in free amino acid tissue pools is important for maintaining an
anabolic drive for protein synthesis (Millward and Rivers, 1989) under conditions of
greater turnover and thus essential for the formation of creatine.
Arginine is normally a nonessential amino acids in humans, but is considered essential
under certain conditions. Studies have pointed tb the essential nature of arginine in a
variety of catabolic conditions, including surgery and trauma and in conditions where
growth is accelerated (Zieve, 1986; Barbul, 1986). As arginine is a precursor of creatine
phosphate, one study has shown that muscle creatine content has significantly increased
by arginine supplementation (along with glycine) (Minuskin et al., 1981). In this study
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supplementing a 25% casein-based diet with arginine and glycine significantly improved
apparent nitrogen retention both in untraumatized and traumatized rats. There is also
other direct evidence that oral supplementation of the amino acid arginine leads to
enhanced muscle mass and strength in conjunction with resistance training (Elam et al.,
1989).
The last amino acid in the trio is glycine that is the simplest of the amino acid. While
being a nonessential amino acid, during periods of rapid growth the demand of glycine
may be increased. As mention previously as well as in other studies, glycine used
together with arginine has been shown to increase endogenous creatine levels (Minuskin
et al., 1981; Bucci, 1993). Another important aspect of glycine is that it is an important
constituent of collagen. Nearly one third of amino acid residues in collagen are glycine.
Collagen, an extracellular protein that is organized into soluble fibers of great tensile
strength, occurs in all animals and is the most abundant protein of vertebrates. It is the
major stress-bearing component of connective tissues such as bone, teeth, cartilage, skin
and blood vessels (Di Pasquale, 1997).
Thus all three amino acids playa vital role on their own but to mimic the role of creatine
supplementation they have to combine with one or more of the three.
5.2.2 De novo synthesis.
In humans, the enzymes involved in the de novo synthesis of creatine are located in the
liver, pancreas and kidneys. This means that the creatine is produced outside the muscle
and transported to the muscle via the vascular system. Transamidination occurs in the
kidney between arginine and glycine. Methylation of guanidinoacetic acid by S-
adenosylmethionine, that forms creatine, occurs in the liver. The creatine is then
transported to the muscle. The normal concentration of creatine in plasma is 50 to 100
umolfL (Balsom et al., 1994). It could thus be that due to the complexity of different
places where it is made and the fact that it is actually transported in low concentrations
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argues for creatine supplementation working better than the dietary intake of the
precursors.
5.2.3 Creatine transporters and uptake
The structural and functional characteristics of the transporter responsible for Cr uptake
from the circulation into muscle occurs by creatine entering a number of cell types by a
Na-dependent transporter family. It is related to the taurine transporter and the members
of the sub-family of GABAlbetaine transporters (Bennet et al., 1994; Guimbal and
Kilimann, 1993). The results of an unpublished study (presented May 30, 1997 at the
American College of Sports Medicine Annual Meeting) indicated that ingestion of
creatine with glucose, taurine and electrolytes during training promotes greater gains in
upper extremity lifting volume and sprint capacity as compared to glucose, taurine and
electrolyte ingestion alone (Di Pasquale, 1997).
In a study by Guerrero-Ontiveros and Walliman (1998), they presented evidence for the
existence of two highly related creatine transporter (Crea T) isoforms, which are co-
expressed in all tissues where the CreaT and incidentally also CK, is found, except for the
liver, which according to their results also contains Crea T but no or very little CK. They
also showed that both these highly homologous proteins were down regulated after
chronic administration of external Cr and that this down-regulation is prevented or even
counteracted by 3-guanidinopropionate (GPA), the creatine analogue.
Several lines of evidence support the hypothesis that more than one Crea T exist. Two
Crea T mRNA species of 4.0-4.3 and 2.2-3.0 kb, whose tissue expression patterns differ
from one another, were detected by Northern blot analysis (Gonzalez and Uhl, 1994).
Barnwell et al., (1995) cloned and sequenced two human cDNAs, one Crea Tl,
homologous throughout its length with the rat Crea T sequence and a second Crea T2 ,
encoding a new protein and containing some regions of perfect homology with the Crea T
amino acid sequence, but four segments of unique sequences. Although they did not
present any evidence, they did suggest that Crea T2 mRNA might be transcribed from the
Crea Tl gene, possibly by alternative splicing (Barnwell et al., 1995). Thus from the
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above findings there is evidence to support the existence of two different Crea T mRNA
species, as well as of two Crea T transporter polypeptides with identical N- and C-
termini, as judged by anti-peptide-specific antibodies. The two mRNA also correspond to
the 70 and 55 kDa proteins detected by both the anti-N- as well as anti-C- terminal anti-
peptide antibodies. The differential splicing, therefore must take place in a region of the
mRNA coding for the amino acid sequence between the N- and C- termini (Guerrero-
Ontiveros and Walliman, 1998).
The Cr analogue, 3-guanidinopropionate (GPA), competitively inhibits Crea T activity.
Long term feeding (6-10 weeks) of rats with GPA results in a marked decrease in CP, Cr
and ATP levels in skeletal muscle (Wyss and Walliman, 1994). On the other hand, Cr
supplementation augments Cr uptake and accumulation, thus depending on the dose and
type of substrate used, as well as the time of ingestion, different metabolic adaptations
will occur (Guerrero-Ontiveros and Walliman, 1998). Concerning the Crea T, it can be
that extra-cellular Cr may down-regulate the level of the Crea T expression and its
activity in rat skeletal muscle cell line (Loike et al., 1988).
What happens with human athletes who ingest Cr? Human muscle appears to have an
upper limit for its Cr content of 150-160 mmol/kg dry muscle (as reviewed by Passwater,
1997). This suggests that long term Cr intake influences the synthesis of the Crea T in
order to prevent the accumulation of excessive intra-muscular Cr. The down-regulation
could also be a possible side effect of Cr supplementation (discussed later). It is
inadvisable to consume Cr continuously for longer period of times (more than 3 months)
or to abuse Cr ingestion in order to improve performance at any cost. A creatine-free
period of one month, after 3 months of creatine ingestion would be advisable (Guerrero-
Ontiveros and Walliman, 1998), based on a wash-out time study (Hultman et al., 1996).
Since the functional and structural characteristics of the Cr transporter in muscle has
already been described above, it may be possible to achieve higher levels of Cr in the
muscle by combining other substances with Cr to enhance its uptake into the muscle. By
having the optimal schedule of dosages and timing of Cr administration to maximize
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storage in the muscle, it is important to remember that the level of expression of the Cr
transporter is regulated by the extracellular Cr concentration as was mentioned above.
Thus combining other nutritional ergogenic aids that may promote a synergistic effect
with Cr should be mentioned. In a study by Green et al., (1996), they investigated the
effect of carbohydrate (CHO) ingestion on skeletal muscle creatine accumulation during
creatine supplementation in humans. They concluded that creatine supplementation had
no effect on serum insulin concentration, but creatine and CHO ingestion dramatically
elevated insulin concentration (P<O.OOl). Thus the study demonstrated that skeletal
muscle creatine accumulation could be substantially augmented in humans when creatine
was ingested with CHO, a response that appeared to be insulin mediated and which could
possibly have important implications on maximal exercise performance.
5.3 Creatine in skeletal muscle
5.3.1 Distribution in the body and daily turnover
Creatine is found naturally in skeletal muscle, heart, brain, testes, retina and other tissues
(reviewed by Wallimann and Hemmer 1994). However, virtually all (95-98 percent) of
the body's creatine is stored in skeletal muscles. An average-sized healthy male may have
about 120 grams of creatine stored in his body. The total creatine (Crtot)pool in humans
refers to the combined amount of creatine in its free (Crfree)and phosphorylated (CP)
form. In skeletal muscle, approximately one quarter exists as Crfreeand three quarters as
CP. Creatine is synthesized at a rate of 1-2 g/day (Walker, 1979). In the absence of
exogenous creatine, the rate of Cr and CP being degraded to creatinine via a non-
enzymatic, irreversible reaction is estimated at approximately 1.6% per day (Crim et al.,
1976). The creatinine is filtered in the kidneys and is excreted in the urine. Urine
concentration of creatinine averages about one-tenth that of urea (Passwater, 1997). An
additional 1-2 g/day of creatine is obtained in the diet, mainly from fish and meats ( as
reviewed by Balsom, 1994). Therefore an average-sized man with a total creatine pool of
approximately 120g has a turnover rate of approximately 2g per day, as the lost creatine
is replaced by both endogenous and exogenous sources. It was long believed that the
endogenous synthesis is to some degree regulated by exogenous intake, likely a feedback
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mechanism (Walker, 1960). The data on transporter down-regulation discussed earlier
confirms this early hypothesis.
The richest food source of creatine is animal muscle such as that found in meats and fish
and trace amounts found in some plants. Vegetarians have little creatine in their diets,
thus vegetarians, on a creatine free diet, rely completely on endogenous synthesis
(Balsam et al., 1994).
To enhance sports performance, creatine supplements are usually taken in 5-gram doses,
one to four times a day, as will be discussed later, depending on whether the athlete is in
the loading phase or the maintenance phase. To obtain 5 grams of creatine from steak
would require about 1.1 kg of fresh uncooked meat. This thus strengthens the argument
of rather supplementing than increasing creatine intake in the diet.
Table 5.3.1: Creatine in selected uncooked food items. (Adapted from Balsam et al.,
1994)
FOOD AMOUNT of CREATINE (g/kg)
Beef 4.5
Cod 3
Cranberries 0.02
Herring 6.5-10
Milk 0.1
Pork 5
Salmon 4.5
Tuna 4
5.3.2 Gender and age
There are very few studies to date that can be found in the literature that compare the
levels of Crfreeand CP in the skeletal muscle of males and females (Forsberg et al., 1991;
Rehunen et al., 1980). Forsberg et al., (1991), however did find that females have slightly
54
Stellenbosch University http://scholar.sun.ac.za
higher values of Crtat in relation to tissue mass, but there has been no further evidence
with regard to total creatine content to suggest whether or not a difference actually exists
between males and females.
How aging can have an effect on Crtatwas studied by Moller et al., (1980), who deduced
that there was no significant difference between the Crtat levels of young (18-36 yrs) and
elderly (52-79 yrs) individuals. But he did find that the level of Crfreewas higher and CP
was lower in the elderly individuals (Moeller et al., 1980). This could imply that there
might be a difference in the CK equilibrium constant.
5.3.3 Creatine and muscle fiber types
Separation of type I and type II fibers from human freeze dried muscle biopsy samples,
showed that type II (fast twitch) fibers of human skeletal muscle sampled in the resting
state, had a higher content of CP than type I (slow twitch) fibers (Soderlund et al., 1992;
Tesch et al., 1989). These data support other studies showing higher levels of CP in fast
twitch than in slow twitch muscle fibers in a resting state or similarly vastus lateralis vs.
soleus muscle in humans (Essen, 1978; Edstrom et al., 1992).
CP levels were also different between fiber types after exercise. During 30 seconds of
maximal exercise the CP levels in type II fibers dropped below those of type I fibers.
After a recovery period of 60 seconds the CP levels of the type I muscle fibers were still
considerably higher than those of the type II fibers, thus type I fibers have a greater
ability to resynthesize CP during recovery (Tesch et al., 1989). The fact that type I
muscle fibers have a greater capillary density and higher activities of oxidative enzymes
may help with recovery of CP. The implication for supplementation is that type II fibers
would benefit more.
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5.4 Creatine Metabolism
5.4.1 Creatine and Creatine Phosphate as Temporal Energy Buffer
During intense muscle contraction, usually a physical activity of a short and intense
duration, the energy required is provided by the high-energy phosphates, ATP and CP,
found in the muscle (McArdle et al., 1991). Immediate regeneration of ATP is needed if
muscle contraction is to continue. For the first few seconds, the ATP regeneration is
dependent on the re-phosphorylation of ADP from the breakdown of CP, that supplies the
high-energy phosphate required for quick resynthesis of ATP from ADP, which is
accomplished rapidly under anaerobic conditions via the following pathways.
PCr +ADP +H f-- cx~ ATP + Creatine
The reaction shifts to the right when there is muscle contraction and ATP is hydrolysed to
ADP and shifts to the left by the removal of ADP at energy generating sites (Demant and
Rhodes, 1999).
The creatine kinase (CK) enzyme controls the reaction; and
Glucose/glycogen +ADP H ATP + lactate (anaerobic glycolysis)
5.4.2 Creatine/Creatine Phosphate as a Spatial Energy Buffer: The Phosphocreatine
Energy Shuttle
In this concept, CP is postulated to act as an energy carrier, transporting energy from the
mitochondria to different ATPase sites in the cytosol. Bessman formally proposed this
diffusion process in 1972, referring to it as the" phosphorylcreatine shuttle" (Bessman
and Geiger, 1981). This CP energy shuttle involves 3 areas: (1) a peripheral terminus
located outside the utilization site, with regards to muscle is the myosin heads; (2) an
energy generating terminus which is located at the mitochondria and (3) a transferable
space between the areas of production and utilization (Volek et al., 1996).
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When the CP molecule is broken down by one of the isoforms of creatine kinase (CK),
providing a high energy phosphate for ATP resynthesis, there is the diffusion of Crfree
towards the mitochondrial membrane. At the membrane, the creatine is phosphorylated
via another of the CK isoforms, using the high-energy phosphate from the breakdown of
ATP to ADP, ATPase, in the mitochondrial membrane. The newly re-synthesized CP
diffuses back to the myosin heads where its energy is once again used for ATP re-
synthesis (Bessman and Geiger, 1981). The net bout of exercise can now occur (usually
anaerobic). This shuttle system may also be important during aerobic exercise or in the
facilitation of recovery after exercise. Thus, in normal subjects, the CP shuttle acts as a
"spatial energy buffer", providing for more efficient energy transport between sites of
ATP synthesis and utilization (Bessman and Geiger, 1981).
The onset of lactate accumulation is a direct result of an increase in glycolytic flux, which
is needed to meet the increased energy demands that occur during maximal exercise. At
this time the muscle CP content also decreases, due to a need to rapidly re-synthesize
ATP. It has been reported that glycolysis may be stimulated by a decline in CP levels,
leading researchers to suggest that phosphofructokinase (PFK), a key glycolytic enzyme,
is at least partly inhibited by CP. Therefore, during intense physical activity CP
decreases, PFK becomes less inhibited and the rate of glycolysis increases, producing
more ATP for active muscle (Demant and Rhodes, 1999).
5.5 Creatine Supplementation
5.5.1 Dosing and the effects on muscle [TCr) and [PCr)
For creatine supplementation to be effective, it must increase the amount of Crtotor CP
within the muscle and these increased stores must help rapidly replenish ATP during
exercise. Many supplementation strategies have been used in various attempts to increase
[Crtot]and especially [CP]. The typical creatine supplementation protocol begins with a
loading dose of 20 grams/day of creatine monohydrate for 5-7 days, followed by a
"maintenance" dose of 2 grams/day (Hultman et al., 1996), although some studies used
lower doses or supplemented for fewer days. The following table lists successful creatine
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supplementation studies to check the extent of increase in muscular creatine and/or
creatine phosphate levels.
TABLE 5.5.1: A table of some successful creatine supplementation studies that used
muscle biopsies to check the extent of increase in muscular creatine and/or creatine
phosphate levels.
1992
Investigator Year Dosage Days
Harris et al. 20-30g 2-10
Mean
%
increase
in
[Crtot]
20-40%
Casey et al. 1996 20g 5 18%
Result
There was a significant increase in [Crtot],of
which 20-40% of the increase of [Crtot]was
accounted for by [CP].
The muscle uptake of oral Cr was greatest
in the first 2 days (32%), with smaller
increases in subsequent days.
About 20% of the creatine increase was due
to increased CP levels.
There was also an increase [CP] of about
10% following supplementation
Hultman et al. 1996 20g or 6 or 28 20%
3g
Greenhaff et 1994a 20g 5 25%
al.
This was a rapid protocol of 6 days together
with a slow protocol of 28 days.
The elevated [Crtot] was maintained when
supplementation was continued at 2g1day.
Although [CP] increased, the increase was
not significant in each separate group
studied, but was significant when the results
of the groups were combined.
No statistical significant increase in [CP].
However there was 35% increase in PCr
resynthesis after muscle contraction. These
results led researchers to propose that there
were responders and non-responders to
creatine supplementation.
There were however studies that did not show statistically significant increases in
creatine. An example was one study in which subjects used only 2 grams of creatine
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monohydrate/day for 6 weeks and showed no beneficial effects on either muscle Crtotor
CP levels (Thompson et al., 1996).
Some studies have highlighted individual differences in response to creatine
supplementation. In Greenhaff et al., (1994b), they noted that the individuals that had the
greatest increase in muscle [Crtot],were mostly those who had subnormal levels before
supplementation. Subnormal levels are 120 mmol creatine/kg dry matter or less.
Individuals that have higher levels of muscle creatine are less responsive to creatine
supplementation (Melvin et al., 1998). But other factors also influence the efficacy of Cr
loading.
A study by Green et al., (1996), found that addition of a carbohydrate solution (90 grams,
4 times daily in solution with creatine during the loading phase) further enhanced the
increase in muscle creatine concentration relative to taking creatine alone. Based on this
study, the combination of creatine with sports drinks has become popular. Skeletal
muscle also has a maximal creatine storage capacity of 150-160 mmol/kg, which makes
over-supplementation futile (Casey et al., 1996). Any excess creatine ingested will not
further increase muscle creatine but will simply increase urinary creatine and creatinine
excretion.
Muscle concentrations of Cr and CP, as well as urinary creatine and creatinine
concentrations, return to baseline levels approximately 28 days after discontinuing
creatine supplementation (Hultman et al., 1996). Because of individual variability, the
"wash out" time in future cross over studies should be at least 5 weeks (recommended by
Juhn and Tarnopolsky, 1998).
5.5.2 Caffeine and creatine supplementation
As creatine uptake into the muscle is dependent on extracellular Na+, thus adrenergic
stimulation of the sarcolemma might enhance muscle creatine uptake via the increased
activity of the Na+, K+ ATPase pump (Vanderberghe et al, 1996). Therefore caffeine
consumption has been hypothesized to improve the efficacy of creatine supplementation.
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In Vanderberghe et al, (1996), they looked at and compared creatine uptake, isometric
force and isokinetic knee-extension torque production in nine healthy males following 6
days of either creatine supplementation (0.5 glkg/day) or creatine (0.5 glkglday) in
combination with caffeine (5 glkg/day). There was a 3-week washout period between
treatments. The results were that [CP] increased after both treatments and torque only
increased after Cr supplementation without caffeine. Thus a conclusion was reached that
caffeine eliminates the ergogenic effect of creatine. However criticism could be raised
about the short wash out period.
Since both creatine and caffeine may facilitate human performance, another study was
also conducted to assess the effects of creatine and caffeine alone and in combination, on
short term maximal performance and endurance performance in trained athletes
(Vanakoski et al., 1998). The results were that creatine had no beneficial effects on
maximal anaerobic performance or on short-term recovery from it in trained athletes.
Likewise, caffeine and the combination of creatine and caffeine failed to produce any
beneficial effects on anaerobic or aerobic endurance performance (Vanakoski et al.,
1998).
5.5.3 The effects of creatine on body composition.
Creatine supplementation results in weight gain, from 0.5 to 1.6 kg during a 5 day
loading phase (Greenhaff et al., 1994; Dawson et al., 1995; Barnett et al.,1996) and even
more with prolonged use (Vanderberghe et al.,1997). The weight gain is initially due to
water retention (Vanderberghe et al., 1997) as indicated by decreased urinary volume
during this time.
When combined with physical training, Cr supplementation may lead to an increase in
lean body mass. A study on male and female track athletes reported that there was an
increase in lean body mass of up to 4.8 kg, as estimated by skin-fold measurements
following 6 weeks of creatine supplementation (20 grams a day), (Kirksey et al., 1997).
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Findings like these suggest that Cr supplementation can lead to an increase in lean body
mass, but how it exactly works or what causes it is still not completely understood, it
could be water retention or protein synthesis. More research is still needed.
5.5.4 Potential side effects of creatine supplementation
Adverse effects of oral creatine have not been extensively studied, though concerns have
been prevalent in the media. Thus far it seems that creatine is safe, there have been no
adverse effects reported except some gastric upset. Muscle cramping is a common report
from athletic trainers. Since water retention occurs with creatine supplementation
(Hultman et al., 1996), it is speculated that this effect increases skeletal compartment
pressure, leading to the risk of muscle dysfunction. In some studies that have monitored
performance (Vandenberge et al., 1997; Kreider et al., 1998) none of the subjects
experienced muscle cramping. However these studies had sample sizes of 25 or less
which is sub-optimal for comprehensive statistical analyses of side effects.
Diarrhea and gastrointestinal pain have also been reported anecdotally. Once again
performance studies reported none of these symptoms and again the samples were too
small. It can be understandable that 20 grams a day for 5 days can be excessive for some
digestive systems as the average diet only includes 1-2 grams a day.
Two published case reports of renal dysfunction in subjects taking creatine have raised
some concerns (Pritchard et al., 1998; Koshy et al., 1999). Short-term (5 day) creatine
supplementation does not appear to impair function in the healthy kidney.
Supplementation can increase urinary creatine excretion rate 90-fold, long term adverse
affects are unclear (Vandenberge et al., 1997). The only advice is that people with pre-
existing renal disease and those with a potential for renal dysfunction (diabetes) should
not use creatine supplementation. Other unstudied areas of concern regarding effects of Cr
supplementation are summarised in the table below:
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Cancer risk
Table 5.5.4: Concerns Regarding the Effects of Oral Creatine Supplementation
Cr and CP -creatine kinase system may be involved in cellular oncogenesis
(Bergnes et al.1996). This can only be deduced with long term studies and
then it can be seen whether it is beneficial, detrimental or no effect.
Cardiovascular The effect of long-term oral creatine on cardiac muscle creatine
system concentration and cardiac function is unknown (Mihk et al., 1998). In vitro
studies have shown that creatine may play a role in the development of
cardiac muscle hypertrophy by stimulating protein synthesis (IngwalI, 1975).
There has been no effect with short-term use (Mihk et al., 1998).
Children and Theoretical concerns focus on the extra load imposed on developing kidneys
adolescents and other organs and the effects of creatine on muscle bone junctions in the
skeletally immature. Because the children and adolescent population is not
physiologically analogous to an adult population, studies specific to the 18-
and-under age group are necessary before justifying creatine
supplementation in this select group.
Liver Studies of up to 8 weeks of supplementation show minimal or no liver
enzyme increase (Kreider et al., 1998). It is not known if the suppression of
endogenous creatine synthesis with long-term use is reversible.
Nervous system Creatine is found naturally in the brain tissue (Vandenberge et al., 1997).
The true effect of Cr supplementation on the brain is unknown and further
investigation is needed.
Fluid balance Intracellular fluid retention in muscle may predispose creatine users to
dehydration, but studies are lacking. However most creatine manufacturers
recommend proper hydration.
Reproductive
system
Creatine is found in the testes and the sertoli cells have been identified as a
site of creatine synthesis and Cr and CP are involved in sperm metabolism
(Juhn et al., 1998). The effects of Cr supplementation have not been studied
and the possible concern is the reversibility of the suppression of endogenous
synthesis.
Previous table adapted from: Juhn MS, Tarnopolsky M. Potential side effects of oral
creatine supplementation: A critical review. Clin J Sports Med 1998; 8(4): 298-304.
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5.5.5 Ethics and Legality
Creatine is not a steroid or a drug. Its use as a performance enhancer has not been banned
by the International Olympic Committee. Creatine supplementation is a practice similar
to carbohydrate loading, which is accepted. Since it is present in everyone's blood and
everyone excretes some creatine in the urine, there would be no practical way to test for
creatine supplementation if it were banned. The decision to use creatine as a means to
enhance sport performance is left to the discretion of the individual athlete.
5.6 Creatine and Exercise Performance.
5.6.1 High intensity, short term exercise
Researchers first investigated the ergogenic effects of short-term creatine loading. A
typical study usually consisted of the popular protocol of 5 grams four times a day for 5-7
days. Virtually all studies also had placebo groups that were given a glucose polymer.
Supplementation was usually done in a double blind manner, meaning that neither the
subject nor researcher knew what was being supplemented until the tests were complete.
Due to the fact that the research project in this thesis was conducted on cyclists, this
literature review will focus on the role of creatine on exercise performance in cycling.
For a summary see tables 9a,b and c.
In a study of short term, high intensity « 30 sec) cycle ergometer exercise performance
tests, Balsam et al., (1993a), assigned 16 male subjects to a placebo or creatine
supplement group (25 g/day). The subjects had to undergo two such tests before and after
six days of supplementation. The exercise regimen consisted of ten six-second bouts of
high-intensity cycling at two exercise intensities, 130 revolutions per minute (rpm) or 140
rpm. There were no significant changes in any measured parameters in the placebo group.
Those receiving the creatine supplementation had enhanced performance towards the end
of each exercise bout at 140 rpm, as measured by smaller declines in work output with
fatigue. The creatine group also demonstrated a mean body-weight gain of 2.4 pounds,
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with no significant gain in the placebo group. It could be that the mechanisms responsible
for the improved performance with creatine supplementation were due to both a higher
initial muscle CP availability and an increased rate of CP resynthesis during recovery
periods.
Greenhaff et al., (1994), investigated the effect of supplementation of 20 g/day for 5-days
on cycle performance in six healthy males (2 bouts x 30 sec at 80 rpm and 4 minute rest
interval) in a single-group ordered repeated measures design. The ingestion of creatine
resulted in a 19% increase in [CrtotJand a significant increase in the total work in the
second cycle bout. They also noted a 50% reduction in ATP loss in the second exercise
bout despite increased work performance, suggesting that a possible result of increased
[Crtot]is an attenuation of ATP degradation during high intensity physical activity.
Maximal isokinetic cycle performance (3 x 30 sec at 80 rpm with 4min rest) was
measured by Birch et al., (1994) on 14 healthy males. The design was a double blind
assignment to either placebo or creatine supplementation with testing before and after
supplementation (see table 3). There were significant increases in peak power output (8%
for bout 1), mean power output (6% for bout 1 and 2) and total work (6% for bouts 1 and
2) in the creatine group. When comparing the baseline group to the post-supplementation
tests, there were no changes in bout 3 for the Cr group or any bout for the placebo group.
Birch and colleagues (1994) thus concluded that cycling performance can be improved in
the first two of three maximal 30 second bouts. Creatine ingestion also lead to a lower
accumulation of plasma [NH3], thus suggesting an enhanced effect on muscle ADP
rephosphory lation.
In Balsom et al., (1995), seven physically active, male subjects were used for repeated
bout tests (5 x 6sec with 30 sec recovery periods) on a fixed intensity cycle ergometer.
This was followed by a 10 second maximal bout to determine peak power output, before
and after six days of creatine supplementation (25g/day). After supplementation the
subjects were able to maintain a higher power output at the end of the 10 second bout.
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The enhanced fatigue resistance after supplementation was associated with a greater
[CP].
Dawson et al., (1995), presented two studies in the same report. In the first they measured
sprint performance (6 sec x 6 bouts with a 24 sec recovery between bouts) on 22 subjects
that were either taking creatine or a placebo. There were significantly greater increases in
peak power output and total work in the creatine group. The creatine group also
completed more work in sprint one (in isolation) compared to the placebo group, which is
in contrast to the results for the 10 second performance test in the second study. In this
study he randomly assigned 18 subjects in a double blind manner to either a placebo or
creatine supplementation. He investigated the effects on single bout (10 sec) maximal
ergo-cycle performance. They reported no differences between the groups following
supplementation. This data can be difficult to explain, as the energy systems required for
6-second bouts are predominately ATP and CP, whereas glycolysis can already playa
significant role in the 10 second maximum exercise and therefore reduce any effect of
creatine supplementation.
Barnett et al., (1996) also reported no effect of creatine supplementation on peak power
output or mean power output during sprint cycle performance (7 bouts x 10 sec) in 17
males randomized to either a placebo or creatine group.
In a single group design conducted on a cycle ergometer (2 bouts x 30 sec at 80 rpm with
a 4 min rest) in nine healthy males, Casey et al., (1996), concluded that creatine
supplementation resulted in a significant 19% mean increase in muscle [Crtotlasmeasured
by a biopsy. Total work increased by approximately 4% in both bouts and the increases in
both peak and total work were positively correlated with the increases in muscle [Crtot],
specifically in Type II fibers. They also concluded that the improvements in work output
were related to enhanced ATP resynthesis secondary to increased [CP] in Type II fibers.
Kirksey et al., (1997), reported a significant 13% increase in the creatine group and a
non-significant 5% increase in the placebo group in peak power in all five of the Wingate
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trials (5 x 10 sec with 1 minute recovery). They concluded that creatine supplementation
favourably increased power output.
In the study by Prevost et al., (1997), 18 volunteers were divided into a creatine
supplemented and placebo control group. Creatine supplementation consisted of 18.75
grams/day for 5 days followed by 2.25 grams/day for 6 days. Subjects were administered
three different cycle ergometer intermittent interval training regimens, each with a work
component at 150% of V02max. Creatine supplementation increased time to exhaustion by
61% for 30 second work/60 second rest and 62% for 20 second work/40 second rest for
the second and third tests. A more than 100% increase in time for 10 second work/20
second rest (do as many as possible) first test was shown. The placebo group showed no
change. They concluded that the ability to maintain high-intensity, intermittent exercise is
enhanced by creatine supplementation.
Using a single-blind placebo control design and an exercise protocol of 5 x 15-second
maximal cycle ergometer bouts, Schneider et al., (1997), concluded that creatine
ingestion resulted in a significant 6.5% increase in total work compared to the placebo
control group. Thus creatine supplementation may increase the rate of ATP resynthesis
even in untrained subjects.
Of the 11 studies discussed previously on short term, high intensity « 30 sec) work loads
on cycle ergometers, 9 of the studies reported creatine supplementation having a
successful ergogenic effect and 2 studies reported having no effect. This is sufficient
evidence to show that creatine supplementation combined with such exercise protocols
are successful.
5.6.2 High intensity, endurance exercise.
It has been hypothesized that increased levels of CP could reduce the reliance on
anaerobic glycolysis as a replenishment source of ATP and possibly lead to decreased
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formation of lactate and hydrogen ions and could therefore enhance performance in high
intensity more prolonged exercise activities (60-150 sec)(Febbraio et al., 1995).
Febbraio et al., (1995), noted an increase in intra-muscular [Crtot] following creatine
supplementation. Subjects were tested before and after supplementation (4 x 60sec
sprints followed by a 5th to exhaustion, all at 115-125% of V02max) and also re-tested
after a 28-day washout period where the subjects consumed a placebo for the last 5-days.
There were no differences in duration of the 5th exercise bout between baseline, post-
supplementation and post-washout trials. They concluded that creatine supplementation
has no ergogenic effect on exercise performance when the ATP-PCr energy system is not
the principal energy source.
Jacobs et al., (1997), reported an ergogenic effect in a moderately prolonged anaerobic
exercise activity. Subjects were tested on a cycle ergometer, riding in one bout to
exhaustion at 125% of V02max. They reported that the ride time to exhaustion was
increased significantly following creatine ingestion from l31 to 143 seconds (8.5%),
while the placebo group's time remained unchanged at 128 seconds. In physically active
college students, Prevost et al., (1997) reported a 24% increase (approximately 49 to 60
sec) in continuous cycle ergometer time to exhaustion at 150% of V02max following
creatine supplementation (18.75 g/day for 5 days, then 2.25 g/day for 6 days). Both of
these studies seem to contradict Febbraio et al., (1995). However, Febbraio and
colleagues test was done with the subjects already fatigued. A study design with two
tests, one fatigued and one unfatigued would have been better in retrospect.
Schneider et al., (1997), reported no improvement in cycle ergometer performance (5 x
60 sec all out effort) in nine untrained males following creatine supplementation. It can
be that creatine supplementation is less likely to enhance performance of a maximal
intensity more prolonged test (30-150 sec) due to energy system specificity. In tasks that
rely primarily on fast glycolysis for ATP synthesis, the ergogenic effect of creatine could
be limited. The difference between this study and the two that did not show an effect was
that this study used an "all-out" protocol and measured work done, whereas the other 2
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get an intensity and determined time. Thus it can still be debated whether such subtle
differences in test protocols can alter the mechanism for fatigue and efficacy of creatine.
Barnett et al., (1996), measured cycle ergometer V02peak in 17 active volunteers before
and after creatine supplementation. Creatine supplementation failed to increase the
V02peak.
In a study on cycling performance, Bellinger et al., (2000) used 20 cyclists in either a
creatine or placebo group in a randomized double blind manner. Creatine
supplementation increased muscle [TCr], but did not increase the distance cycled in a
one- hour distance trial. Godly and Yates, (1997), measured time to completion in a
simulated 25km cycling race in which 16 well-trained male and female cyclists sprinted
for 15 seconds every 4 km. There was no significant decrease in time to completion
following creatine supplementation. They concluded that creatine supplementation has no
effect on endurance activity, even when combined with short duration, high-intensity
bouts in well-trained subjects. Thus it can be said that there is very little evidence that
creatine supplementation will enhance performance in exercise activities dependent
primarily on oxidative metabolism of endogenous carbohydrate and fat.
However, the controversy surrounding the shorter duration, high-intensity endurance tests
makes this area still worthy of further investigation. In addition where is the cut-off
between the two shorter endurance studies that were effective and the two long ones
(25km and 1 hour) that were clearly ineffective? Also still a problem is that trained
subjects were seldom used.
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Table 5.6.1: The effect of creatine monohydrate supplementation on various Short term, high intensity « 30 sec); cycle ergometer
protocols on Exercise Performance.
Investigator, N Gender Population Design * CM Days Muscle Description Ergogenic Effect?
Year dose Biopsy
21day
Balsom et al. 16 M Active/well RDBPC 25 6 No 2 intermittent Yes. Attenuated decline in
1993a trained high-intensity power for bouts 7-10
(lOx6)bouts
before and after
loading
Greenhaff et al. 6 M Healthy SGRM 20 5 Yes Isokinetic Yes. Increased total work in
1994 cycling (x2) 2nd test
Birch et al. 14 M Both highly RDBPC 20 5 No 3x30 sec Yes. Increase in peak
1994 and not highly power, mean power and
trained work for bouts 1 and 2
Balsom et al., 7 M Physically SGRM 20 6 Yes 5x6 sec; lxlO Yes. Increase in power
1995 active sec during 10 sec trial
Dawson et al. 18 M Healthy active RDBPC 20 5 No Ixl Osec No.
1995
Dawson et al. 22 M Healthy active RDBPC 20 5 No 6x6 sec Yes. Increase in peak power
1995 and Tot work
Barnett et al 17 M Recreationally RDBPC 20 4 No 7xl0 sec sprint No.
1996 active
- --
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Casey et al. 9 M Healthy SGRM 20 5 Yes 2x30 sec Yes. 4% increase in peak
I1996 power, I% increase in Tot
work
Kirksey et al 36 MIF Track and field RDBPC O.3g/k 42 No Wingate test x5 Yes. 13% increase in mean
1997 athletes g/d peak power
Prevost et al. 18 MIF Active college RPC 18.75 5 No Time to Yes
students exhaustion at
1997 150% V02max
Prevost et al. 2.25 7 2 bouts each of Yes. 61% increase
1997 (2nd study) 30swork/60s Yes. 62% increase
rest Yes. 100% increase
20swork/40s
rest I
10swork/20s
i
rest
Schneider et al. 9 M Untrained RSBPC 25 7 No 5x15 sec Yes. 6.5% increase in total
1997 work (kJ)
* RDBPC = randomized double blind placebo control; RPC = randomized placebo control; RSBPC = randomized single blind placebo
control; SGRM = single group repeated measures
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Table 5.6.2: The effect of creatine monohydrate supplementation on various; High intensity, more prolonged (>30 to <150 sec) cycle
ergometer protocols on Exercise Performance.
Investigator, N Gender Population Design * CM Days Muscle Biopsy Description Ergogenic Effect?
Year dose
glday
Febbraio et 6 M Untrained SGRM 20 5 Yes 4x60s; 115 -125 % No.
al. V02max
1995 5th bout to
exhaustion
Jacobs et al. 2 M/F Physically active RDBPC 20 5 No 125% V02max Yes. 8.5% increase
1997 6 ride to exhaustion in time to
exhaustion; 9%
increase in max
accumulated O2
debt
Prevost et al. 1 M/F Active college RPC 18.75 5 No Time to exhaustion Yes. 24% increase
1997 8 students at 150% V02max
Schneider et 9 M Untrained RSBPC 25 7 No 5x60 sec No.
al .
.1997
* RDBPC = randomized double blind placebo control; RPC = randomized placebo control; RSBPC = randomized single blind placebo
control; SGRM = single group repeated measures
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Table 5.6.3: The effect of creatine monohydrate supplementation on various aerobic (>150 sec) cycle ergometer protocols on Exercise
Performance.
Investigator, N Gender Population Design * CM Days Muscle Biopsy Description Ergogenic Effect?
Year dose
.glday
Barnett et al. 17 M Recreationall y RSBPC 20 4 No V02peak No.
1996 active
Bellinger et 13 M Recreational RDBPC 20 7 Yes Cycle distance in 1 No.
al.,2000 Competitive hour
Godly and 16 MIF Well trained RDBPC 20 5 No 25km simulated No.
Yates cyclists road race with 6x15
sec sprints every
1997 4km
* RDBPC = randomized double blind placebo control; RPC = randomized placebo control; RSBPC = randomized single blind
placebo control; SGRM = single group repeated measures
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Chapter 6: Aims
The aims of this study were:
Study 1: To use the novel approach of using Peak Sustained Power Output (PSPO) as a
predictor of cycling performance for variable fixed-workload testing and 5 km time
trialing.
Study 2: Whether oral creatine supplementation would affect 5 km time trial
performance and metabolism.
We hypothesized that creatine supplementation would affect time trial performance as
well as the appearance of breakdown products of adenine nucleotides in the plasma.
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Chapter 7: Methods and Materials
7.1 Subjects and ethical approval
Thirteen male subjects, between the ages of eighteen and thirty years of age, volunteered
for the study. The cyclists were selected on their proven ability to complete a 105-
kilometer cycle race in less than three hours and twenty minutes as well as being trained
at the start of the study. All the subjects received a study information sheet outlining the
study procedure (Appendix 1). The subjects were also required to complete an informed
consent form (Appendix 2), which allowed them to withdraw at any stage of the study.
The University of Stellenbosch ethical research committee for research with human
subjects passed the study and approved the consent form (The ethical approval of the
Committee of Ethical Evalutation of Research, Sub-Committee B, University of
Stellenbosch, was given on 10May 1999 for the application titled: "The effect of
creatine-supplementation on stochastic exercise performance")
7.2 Experimental Procedure
7.2.1 Study 1: This study involved characterization of the metabolic response to a 5 km
time trial as well as an investigation of physiologicallbiochemical and exercise predictors
of performance. The test period was incorporated in the procedures for Study 2. See
below.
7.2.2 Study 2: The study was a placebo controlled, single blind laboratory experiment to
determine the effect of oral creatine supplementation on 5 km time trial performance and
metabolism after stochastic testing. At no stage of the study were the subjects aware of
whether they were receiving active agent or placebo and were only made aware of
contents at the end of the sample analyses.
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The test period was 4 weeks long. The first week consisted of the initial Peak Sustained
Power Output (PSPO) test, conducted on an electromagnetically braked cycle ergometer
(Technogym®, Bikerace HC 600, Gambettola, Italy) in order to assess the fitness and
cycling power of the cyclists. Two days later the subjects returned to the laboratory with
their own bicycles to conduct the first of two baseline stochastic tests, each followed
directly by a high intensity 5 km time trial in the quickest possible time in each case (STl
and ST2). The stochastic tests were conducted on an electromagnetically braked cycle
ergometer (Technogym®, Bikerace HC 600, Gambettola, Italy), followed directly by a 5
km time trial on a cycle ergometer (Technogym®, Spintrainer, Gambettola, Italy).
In the second week the subjects completed two 5 km high intensity time trials (TTl and
TT2) on the cycle ergometer (Technogym®, Spintrainer, Gambettola, Italy). They were
to complete the test as quickly as possible and the tests were conducted two days apart.
During TT2 blood samples were taken for plasma lactate and plasma hypoxanthine and
urate. A muscle biopsy was taken after TT2 for intramuscular total creatine levels,
histological ATPase fiber typing and SOS gel electrophoresis for MHC seperation.
The 13 subjects were then given sachets containing an unknown substance. Seven
subjects received the active agent, an oral creatine supplement, 5 grams (Phosphagen,
Experimental and Applied Sciences (EAS), ABG, Cape Town) mixed with 20 grams of
glucose polymer (Refuel cc., Observatory, Cape Town) and 6 subjects received sachets
containing 25 grams of a placebo (glucose polymer). The powders were the same texture,
colour and mass. The contents of the sachets were mixed with water and 4 sachets were
consumed 4 times a day. The subjects were then to load for seven days (third week) while
continuing with their regular training program.
In the fourth and final week the subjects returned and conducted another stochastic test
with a 5 km time trial directly afterwards (ST3). Two days later the subjects returned for
a single 5 km time trial (TT3) where blood samples were once again taken for the
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analysis of plasma lactate and plasma hypoxanthine and urate. Approximately 1-2 hours
later a second muscle biopsy was taken for intramuscular TCr and for muscle fiber
typing.
7.3 The Peak Sustained Power Output (PSPO) Test
The test was conducted on an electromagnetically braked cycle ergometer
(Technogym®, Bikerace HC 600, Gambettola, Italy) that had been modified to have
racing handlebars (Acor race-bars), racing seat (Giant, gel-system) and cleated pedals
(Look, clipless pedal system). The cycle ergometers' seat height and handle bar height
was adjusted for each subject and recorded for further reference. The subjects' heart rate
was monitored using a heart rate recording/transmitter belt (Polar®, Finland) that is
compatible with the Technogym® software on the ergometer's computer.
The test commenced with a warm up of up to 10 minutes. The initial exercise intensity
was calculated at 3.33 W per kilogram body mass and was maintained for 150 sec
according to the protocol of Hawley and Noakes, (1992), thereafter the workload was
increased with 50 W for another 150 sec and thereafter by 20 W until exhaustion. The
cyclists remained seated for the entire duration of the test and maintained a cadence of 70
revolutions per minute (rpm) or more. If this could not be maintained the test was ended.
If the last workload could not be completed the peak sustained power output was
calculated according to the formula:
PSPO =Workload (previous) + [(time completed in final workload /150) x 20 W]
The following equation from Hawley and Noakes, (1992). could also be used to calculate
an 'estimated' V02 peak. According to this protocol the correlation reported was very
close between peak workload and V02max (r = 0.97, P< 0.0001).
V02peak (calculated) = 0.01141 x PSPO (W) + 0.435
(Multiply 1000 to obtain the answer in ml/minlkg).
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The subjects' power to weight ratio was also calculated:
Power: weight = PSPO/ body mass =W/kg
This ratio gives an indication of the athlete's training status and racing potential. It was
also used as a variable for correlation with their time trial performance time and other
variables measured during the project.
7.4 The Variable fixed-workload protocol and 5 kilometer Time Trials
Prof. K.H. Myburgh and Mr. C. de Klerk designed this variable fixed-workload protocol.
The test was designed and structured to include some submaximal steady state workloads
(Appendix 3). These were interspersed by shorter time periods at either low intensity or
supra-maximal intensity workloads and followed directly by a 5 km time trial as the final
workload. The stochastic test was conducted on an electomagnetically braked cycle
ergometer (Technogym®, Bikerace He 600, Gambettola, Italy) and the 5-kilometer time
trial on their own bicycles linked to a cycle ergometer (Technogym®, Spintrainer,
Gambettola, Italy). The exercise intensity was expressed as a percentage of the peak
power output. The subjects' heart rates were monitored and recorded after each workload
using a Polar® heart rate electrode belt that is compatible with the Technogym®
software. Each subject conducted two such tests before their loading week (STI and ST2)
and one more after the loading week (ST3). Performance was taken as the duration of the
5 km time trial, since all other workloads were for set durations and the same for each
subject in each test.
The subjects were also required to complete 5 km time trials without a pre- variable
fixed-workload test. These were conducted on their own bicycles, that were attached to a
cycle ergometer (Technogym®, Spintrainer, Gambettola, Italy). Two tests were
conducted before the loading week (TTl and TT2). TTl was used as familiarization time
trial and for repeatability of the tests. During and after TT2, blood samples and muscle
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biopsies were taken. A third and final individual time trial (TI3) was conducted after the
loading week where once again blood samples were taken as well as a muscle biopsy.
7.5 Sample Handling and Analyses
7.5.1 Blood.
Blood samples were taken at specific time points before, during and after TI2 and TI3.
Blood was drawn using an in-dwelling cannula (Jelco™, 22G, Johnson and Johnson
medicine, RSA) and stopcock (RE/NMIstopcock, GRS medical, RSA) inserted into a
forearm vein. The cannula was flushed with sterile saline (0.9% sodium chloride, Adcock
Ingram, Johannesburg, RSA) containing lml of heparin Novo (Novo Nordisk (Pty) Ltd.,
Johannesburg, RSA) per 100ml saline.
Blood samples for plasma lactate were taken at rest, 3 minutes into the time trial, at the
end of the time trial and at 2, 4, 7, 10 and 20 minutes of recovery. Blood samples for
plasma hypoxanthine and urate were drawn at rest, at the end of the time trial and at 4,10
and 20 minutes of recovery. Prior to taking each sample, approximately 1 ml of blood
was drawn and discarded, due to the "dead space" from the saline flushing. Following
this approximately 4 ml of blood was drawn on each occasion with a syringe. The blood
was then alliquotted in 5 ml evacuated tubes (Vacutainer, Becton Dickson, Plymouth,
UK) mixed well with the contents of the tubes and kept on ice. Two types of evacuated
tubes were used, a Grey-top tube (containing sodium fluoride and pottasium oxalate) for
lactate analysis and a green-top tube (containing lithium and heparin) for the analysis of
hypoxanthine and urate. The blood was then centrifuged (Sarstedt LC l-K centrifuge,
Optolabor, Randburg, RSA) at 3000 rpm's for 10 minutes at 3°C. After separation, lml
of plasma was removed using disposable Pasteur pipettes (Volac, John Poutten Ltd.,
Essex, England) and placed in marked 1.5 ml Eppendorf storage vials and stored at -
20°C for later determination of lactate, hypoxanthine and urate concentrations.
Lactate was analyzed using a commercially available kit (Lactate PAP, BioMerieux,
Seperation Scientific, Honeydew, RSA) and spectrophotometer (Cary 50 cone, UV
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visible spectrophotometer, Varian Australia (Pty) Ltd., Mulgrave, Australia). Pippetting
was done using digital micro-pipettes (Autoclavable Nichipet, Model 5000DG, Nichiryo,
Tokyo, Japan). Lactate concentrations were calculated using Microsoft Exel™
spreadsheets. There was less than a 3% error in repeatability in 90 samples done in
duplicate. A further 14 samples were between 3-5% in error. These were repeated in
duplicate and in all cases the error was then less than 3%. (% error = ABS 1 - ABS2/
(ABS1 + ABS2)/2 * 100.
The determination of hypoxanthine and urate was done using the High-performance
liquid chromatography (HPLC) analyses. Plasma hypoxanthine and urate were analyzed
using a Gilson Instruments HPLC (Gilson Inc., Middleton, U.S.A). It consisted of a
Gilson 305 pump, a Rheodyne 7125 injection valve (Rheodyne, California, U.S.A) and
Gilson UVNIS detector (119UV). The column used was a Phenomenex Ultracarb 5 ODS
(two linked 150 x 4.6 mm columns). This analysis method utilized a mobile phase of
phosphate buffer. The mobile phase buffer was made up of 90 mM potassium dihydrogen
phosphate buffer (ACS reagent grade, ICN Biomedical Inc., Ohio, USA), 5% HPLC-
grade acetonitrile (BDH, Hypersolv, England) and 2.3 mM tetra-butyl-ammonium
hydrogen-sulphate (Merck, Schuchardt, Germany). The buffer was then titrated to pH 6.5
using 40% KOH and made up to volume using distilled 18 MOhm water. Following this
the buffer was filtered and degassed. The flow rate was set at 0.9 mlImin and the total run
time was 8 minutes. Integration of the peaks was only begun after 4 minutes of the run.
Stock standards were made up to volume with mobile phase buffer and frozen. These
were defrosted at the start of every analysis day. The plasma samples were extracted and
this method involved adding 100, .tl of plasma to 100, .tl of ice-cold 0.6M perchloric acid
(Merck, Germany). The sample was then centrifuged in a micro-centrifuge (Beckman
Microfuge® Lite, Beckman, Germany) for 4 minutes at 11500 rpm. Following this 150
,.tl of supernatant was removed and neutralized with 9 ,.tl of 2.5 M K2C03 anhydrous
(BDH Laboratory supplies, Poole, England). This sample was then placed on ice for 10
minutes and again centrifuged for 4 minutes at 11500 rpm. After centrifugation 100 ,.tl of
supernatant was drawn off and made up to 500 J..lI with 400 J..lI mobile phase buffer. The
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mobile phase buffer was made up to be the same as the buffer discussed previously of 90
mM potassium dihydrogen phosphate buffer (ACS reagent grade, ICN Biomedical Inc.,
Ohio, USA), 3.5% HPLC-grade acetonitrile (BDH, Hypersolv, England) and 2.3 mM
tetra-butyl-ammonium hydrogen-sulphate (Merck, Schuchardt, Germany). The buffer
was again titrated to pH 6.5 using 40% KOH and made up to volume using distilled 18
Mohm water. The sample was then injected onto the column. The injection volume was
20 JlI of sample. Both hypoxanthine and urate were detected at 249 nm and analysis was
performed according to area. This method provided good resolution peaks in both
standard and sample runs.
7.5.2 Muscle.
Muscle biopsies were taken on two occasions once after TI2 and once after TI3. The
samples were removed from the vastus lateralis muscle using a stainless steel Trephine
biopsy needle (6 mm). The muscle biopsies were performed under sterile conditions and
performed by a medical doctor with experience in this procedure. Prior to incision the
skin was prepared and cleaned with a disinfectant (Betadine® antiseptic solution,
Adcock Ingram Pharmaceuticals, Johannesburg, RSA) for administration of local
anaesthetic. Four milliliters of local anaesthetic (Peterkaien, 2% miv injection, Intramed
(Pty) Ltd., Port Elizabeth, RSA) was injected below the skin to the level of the muscle
fascia and sufficient time was allowed for the anaesthetic to take effect. A scalpel
incision was then made through the skin and fascia to the level of the muscle. The muscle
biopsy needle was then inserted and two muscle samples taken immediately, the second
after turning the needle ± 90°. The first muscle sample was placed in liquid nitrogen
within 10 seconds of the biopsy needle being removed from the vastus lateralis and the
second sample was mounted on cork and Tissue Tek, a mounting compound, was applied
to the sample where it was then placed in semi-frozen isopentane for muscle
histochemistry .
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Pressure was then applied to the wound until the bleeding stopped. The wound was again
disinfected (Betadine® antiseptic solution, Adcock Ingram Pharmaceuticals,
Johannesburg, RSA) and closed using Steristrip™ skin closures (3M, reinforced skin
closures, 6mm x 75mm, Borken, Germany). This was then covered with Tegaderm™
(3M, transparent dressing, 6cm x 7cm, Ontario, Canada). The leg was then bandaged
(Premier, conforming bandage, 75mm, manufactured by Megrotex, RSA) and the subject
was then given Paracetamol (500mg) tablets for pain relief as the anaesthetic subsided, to
be taken 1 or 2 tablets every four hours as needed.
The first muscle sample that was frozen in the liquid nitrogen was then placed in Cryo
vials™ (Greiner labortechnik), weighed and stored at -80°C until analysis for total
creatine (TCr) and muscle nucleotide content, which was conducted using the HPLC
method. Before the muscle could be used for HPLC analysis the samples had to be
freeze-dried in a vacuum (Christ LDC-l freeze-dryer with sliding vane rotary vacuum
pump, Vacubrand, Wertheim, Germany) in little glass containers which could be stored
until analysis at either room temperature or -20°C, without breaking the vacuum seal
until just prior to weighing the sample. At this time, the container needed to be
equilibrated to room temperature.
The HPLC method is based on a combination of that described by Sellevold et al., (1986)
and Ally and Park (1992). Certain modifications were made to provide better resolution
of peaks. A Gilson Instruments HPLC (Gilson Inc., Middleton, U.S.A) was used. It
consisted of a Gilson 305 pump, a Rheodyne 7125 injection valve (Rheodyne, California,
U.S.A) and Gilson UVNIS detector (119UV). The column used was a Phenomenex
Ultracarb 5 ODS (two linked 150 x 4.6 mm columns). The flow rate was set at 0.9
mlImin for the full run time of 30 minutes. A gradient of 20% acetonitrile buffer B was
also run during the 30 minutes. This buffer was injected at 6-minutes and the percentage
of the two buffers was at 50% each at the 13th minute and continued as such until the
23rd minute and then buffer B slowly decreased to 0% by the 26th minute and the run
then continued with buffer A till minute 30. The injection loop consisted of 20 !-lI of
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sample. This method used consisted of a mobile phase of phosphate buffer, the same used
for the plasma analysis, made up using 90 mM potassium dihydrogen phosphate buffer
(ACS reagent grade, ICN Biomedical Inc., Ohio, USA). The buffer was then filtered and
degassed. Standards were made up using mobile phase buffer and were divided into
aliquots and frozen at -18°C. Fresh standards were defrosted every morning and mixed
together to form a combination of all the compounds expected in a muscle sample run.
Thus a high and a low standard mix were made up for injection onto the column.
Standard runs were repeated at regular intervals during an analysis day.
The creatine values had to be corrected to an equal nucleotide (ADP and ATP) value for
each subject's pre- and post-loading biopsy before the comparisons between the placebo
and creatine groups could be made (see chapter 8 for discussion).
The second muscle sample that was frozen in isopentane was used for muscle
histochemistry. It is a delicate freezing procedure (Appendix 4) that had to be conducted
correctly for ideal muscle sections. The mounted sample was then cut into 10 urn
sections in a cryostat (Cryostat) at -18°C. Sections were mounted on cover glasses or
glass slides. The sections were then allowed to air dry for at least 30-minutes before
staining or were alternatively stored at -80°C to be stained the next day.
Myosin ATPase staining was conducted using the method by Brooke and Kaiser,
(1970a). It consisted of 3 buffers being made up: A veronal buffer with pH 9.4 and a 0.2
M acetate buffer with pH 4.3 and pH 4.6 respectively. A substrate incubation solution
with pH 9.4 was also made up (Appendix 5). With this method the result was that 3 fibre
types, I, lIA and lIB (also called lIX), were discriminated between and thus the fibers
could be typed.
The muscle samples were also analyzed using the SDS-polyacrylamide gels, used for
myosin heavy chain (MHC) separation. In this method the muscle samples that were used
were cut from a Tissue-Tek embedded biopsy (15 sections of 15 urn each) and placed in
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a denaturation buffer (Appendix 6). Two SOS-gels were used to run the samples, a
separating gel and a loading gel (Appendix 6). In both the separating and loading gels
polymerization was initiated by ammonium per-sulphateffEMED (Fry et al., 1994). The
gels were run for 48 hours at 70 volts. Subsequently the gels were stained with Coomasie
R250 and the relative amount of MHC isoforms were quantified using a densitometric
system (Cream 1-0, Kem-en-Tec Aps, Copenhagen, Denmark.
7.6 Statistical Analysis
Statistical analysis was performed on NCSS 2000 statistical system (Number Cruncher
Statistical Systems, Kaysville, Utah, USA). Repeated measures ANOVA tests were
conducted for the analysis of the blood metabolites. The data in the tables were presented
as mean values and standard deviations (SD) of the mean. Students' t-test was used
where appropriate. The accepted level of significance was P:::;0.05.Results were also
recorded as mean ± 1 standard deviations (SD).
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CHAPTER8:RESULTS
8.1 Subjects: Thirteen male subjects volunteered for this study. All subjects were trained
cyclists. The study fell within the cycling season (summer). All subjects had completed a
105 km race within the previous racing competitive season and were training for the same
race at the time of participation in the study. Subject characteristics are presented in
Table 1.
TABLE 1: Subject Characteristics.
;:,~'-~~~~\f,;EI,~;~~tf{'j::_ !~~~~"; ;~~~~~:~m~;~~I}:"
1 18 72 185 169
2 25 74 176 167
3 18 68 175 196
4 26 73 184 182
5 18 56 160 181
6 22 73 187 184
7 22 88 197 197
8 20 67 187 200
9 20 68 180 179
10 18 67 181 172
11 20 67 185 181
12 19 64 182 179
13 25 80 180 199
Mean 20.8 70.5 181.5 183.5
sn 2.9 7.8 8.5 11.3
PSPO = Peak Sustained Power Output
SD = Standard Deviation
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324 4.5
368 5.0
336 4.9
380 5.2
273 4.9
383 5.2
395 4.5
352 5.2
336 4.9
340 5.1
345 5.2
323 5.1
360 4.5
347.3 4.9
31.9 0.3
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8.2 STUDY 1
8.2.1 Performance data:
The major laboratory performance trial was the 5 km time trial. The repeatability of the 5
km TT was good: the percentage error between TTl and TT2 for individual subjects
ranged from -0.95% to l.8%. The coefficient of variation was: 0.6% for all subjects.
Therefore, we used the average of TTl and TT2 as the major performance measure,
hereafter called TT mean.
The 5 km TT was also performed twice under fatigued conditions, after 32 minutes of
stochastic exercise. The repeatability was also good: the percentage error between STI
and ST2 for individual subjects ranged from -2.19% to 1.12%. The coefficient of
variation was 0.7%. Therefore, we used the average of ST1 and ST2 as the major
measure for performance under fatigued conditions. There was a significant difference
between 5 km TT performed fresh (TT mean) and 5 km TT performed fatigued (ST
mean) (P=O.OOOl).For mean values see Fig. l. There was defmite fatigue with a
decrement in time ranging between 1.0 sec to 38.0 sec for individual subjects with a
mean of 18.2 ± 1l.9 sec (SD).
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FIGURE 1: The 5-km time trial performances.
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c 07:31.9
! 07:25.0cu
E 07:18.0j::
07:11.1
07:04.2
06:57.3
06:50.4
STmean TT mean
* P= 0.0001 (Table of means ± SO in Appendix 8)
Abbreviations :
ST mean = the mean value of two 5 km time trials (STI and ST2) performed under
fatigued conditions after 32 minutes of stochastic testing.
TT mean = the mean value of two 5 km time trials (TTl and TT2).
8.2.2 Relationship between different measures of exercise performance:
PSPO is usually used as the "gold standard" for determining endurance performance in
the laboratory. We determined the relationship between two different high intensity
endurance performance tests: PSPO and 5 km TT (TT mean). The correlation was: r=-
0.79 P<O.Ol. The correlation between PSPO and the 5 km TT performed in the fatigued
condition (ST mean) was slightly worse: r= -0.60 P<0.05.
We also related power to weight ratio (pSPO/kg) to time trial performance, but there
were no significant correlations: PSPO/kg vs. 5 km TT was r = -0.26 and PSPO/kg vs. 5
km TT in the fatigued state: r = -0.47.
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Performance in the 105 km race was also not related to any of the laboratory performance
measures.
TABLE 2: Non-significant correlations between 105 km race time and different
laboratory measures of exercise performance.
105 km
PSPO r= 0.25
TT mean r= -0.21
STmean r = -0.24
PPOlkg r= 0.08
The relationship between the physical variables (age and mass) and performance
variables (105 km time, PSPO, TT mean and ST mean) were correlated. A good
relationship was found between age and PSPO (r= 0.73; P<0.05). Age also showed a
good negative relationship with TT mean (r=-0.71; P<0.05). A very good relationship
was found between body mass and PSPO (r = 0.85; P<O.Ol) but not between body mass
and TT mean. No significant relationships were found between the physical variables and
105 km time and STmean
8.2.3 Metabolic variables:
Plasma lactate concentrations were determined at various time points during TT2 (Fig. 2).
Plasma lactate concentrations were significantly different from rest at all other time
points (P<O.OOOl).The other time points were at 3-minutes into the time trial and at
recovery from time zero to 20 minutes (see Fig. 2). Hypoxanthine (P<O.OOOI)and urate
(P=O.05) concentrations were also significantly different from rest at all other time points.
The time points recorded were at rest and during recovery at time zero, 4, 10 and 20
minutes. (see Fig. 3 and Fig. 4). Thus the repeated measures ANOVA reached
significance and that post hoc testing showed the resting value to be significantly
different to all other values. Using the data provided in the appendix, there were
differences between many of the other time periods.
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FIGURE 2: The concentrations of plasma lactate before, during and after TT2. (Table of
means ± SD in Appendix 9). .. ANOV A, P<O.OOOI
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FIGURE 3: Concentration of plasma hypoxanthine before and after TT2. (Table of means
± SD in Appendix 9). .. ANOV A, P<O.OOOI
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FIGURE 4: The concentrations of plasma urate before and after TT2. (Table of means ±
SO in Appendix 9) 'Ir ANOVA, P=O.05
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8.2.4 Relationships between exercise performance (TT2) and metabolic variables.
The relationship between recovery time and metabolite concentrations was notable for
plasma lactate. The plasma lactate concentrations were at their highest at times 0, 2 and 4
minutes, but there was hardly any recovery in the concentration of plasma lactate for 20
minutes following this high intensity endurance exercise bout. The area under the curves
for the lactate concentrations for all the subjects, (Fig. 5), were calculated and the results
were correlated with TT2. The result was a weak non-significant correlation ofr = 0.28.
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FIGURE 5: Individual curves for the subjects (n=13) for plasma lactate concentration.
Plasma hypoxanthine levels were also affected by the intensity of the 5 km time trial
(TT2). Hypoxanthine concentrations reached their peak at 10 min post-exercise. The area
under the curve for hypoxanthine was calculated for all the subjects (n=13) and correlated
with TT2 and a non-significant correlation of r = -0.16 resulted.
The plasma urate concentrations also increased due to the intensity of TT2. The
concentrations did not increase considerably in comparison to the resting values but the
concentrations remained at a high level and plateaued even after 20 minutes of recovery.
The correlation of the area under the curve for urate and TT2 performance time resulted
in a non-significant value ofr = -0.33.
8.2.5 Muscle physiology variables:
We determined myosin heavy chain composition in homogenates from a portion of the
muscle biopsies frozen in Tissue-Tek. Percentage MHC I was 58.3 ± 10.6 (SD) and
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percentage MHC IIa was 40.8 ± 11.0 (SD). Only one subject had any type IIx fibres
(1l.7%).
Histological fibre typing was done for one subject as a case study. The results for the
ATPase staining method were fiber type I: 42%, type IIA: 57% and type lIB: 1%. The
same subject's %MHC isoform distribution was %MHC 1= 37.6 and %MHC na was
62.4.
There were no significant relationships between exercise performance variables and
muscle physiology variables.
TABLE 3: Non-significant correlations between %MHC composition and exercise
performance variables.
MHCI MHCIIa
PSPO r= 0.06 r= 0.15
PSPOIkg r=0.04 r= -0.03
IOS-km r= -0.24 r= 0.26
ST mean r= -0.18 r= -0.01
TTmean r= -0.28 r= 0.18
There were significant correlation between plasma lactate concentration at time 0 in
recovery (i.e. at completion ofTT2) and % MHC I (r=0.59, P<0.05) and % MHC Ha (r= -
0.61, P<0.05). The areas under the curve for lactate resulted in non-significant
correlations of r= 0.16 and r= -0.10 for %MHC I and % MHC na respectively.
There were significant correlations between plasma hypoxanthine concentration and
%MHC I and %MHC Ha at time 0 and time 10 min during recovery. Area under the
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curve for hypoxanthine showed significant relationships of r= -0.53 (P=O.05) and r= 0.56
(P<0.05) respectively for %MHC I and %MHC Ua.
Plasma urate concentrations at the same time points also showed no significant
correlations with %MHC I and %MHC Ha. The correlation between %MHC I and the
areas under the curve for the subjects had a non significant correlation r= 0.04
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8.3 STUDY2:
The same 13 male subjects participated in a nutritional intervention trial to determine
whether oral creatine supplementation would influence 5-km time trial performance in a
fresh as well as in a fatigued state. After randomisation it transpired that 7 subjects were
in the creatine group and 6 subjects in the placebo group. The group characteristics are in
the underlying table and presented as means ± SD. There were no statistically significant
differences between the two groups for any of these variables.
TABLE 4: Subject characteristics for the creatine (n=7) and placebo (n=6) groups.
(Statistical analysis by unpaired Students t-test: not significant).
Placebo 20.33
±2.73
69.83
±5.78
182.00
±4.56
188.33
±11.67
Creatine 21.29
±3.20
71.14
±9.60
179.43
±9.86
349.00
±21.03
5.02
±0.28
181.00
±11.28
345.86
±40.73
4.88
±0.28
Performance times were compared for the 5 km time trials: TT mean and TT3. The times
recorded after the loading week were slightly slower for both the placebo and creatine
groups, but not significantly so. The 5 km performance times recorded by the creatine
group were, pre-loading time 7 min 12 sec± 11.4 sec (SD) and post-loading 7 min 13 sec
± 13.8 sec and the placebo control group recorded times for pre-placebo 7 min 20 sec ±
18.3 sec and post-placebo 7 min 21 sec ± 24.3 sec (see Fig. 6). When looking at
individual results, 2 subjects in the placebo group were slower for TT3 than TTmean and
4 subjects in the creatine group were for TT3 than TT mean.
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•FIGURE 6: The comparison of 5 km time trial performance for the creatine (n=7) and
placebo (n=6) groups before and after 7 days of creatine loading or placebo. (Table of
means ± SD in Appendix 8)
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A 5 km time trial in the fatigued state was also conducted (ST3) after the loading phase.
This performance time was compared to ST mean. The creatine group showed a non-
significant improvement in performance time after the 7-day loading period (pre-load 7
min 34 sec ± 14.5 sec and post-load 7 min 23 sec ± 9.8 sec). The placebo group also
showed a non-significant improvement in performance time (pre-placebo 7 min 29 sec ±
16.0 sec and the post-placebo 7 min 23 sec ± 25.4 sec) (see Fig. 7) (Table of means ± SD
in Appendix 8). When looking at individual results, two subjects in each group had
slower ST3 than ST mean, whereas the other subjects were faster.
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FIGURE 7: The comparison between 5 km time trial performance times in the fatigued
state between the placebo (n=6) and creatine (n=7) groups before and after 7 days of
creatine loading and placebo.
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8.3.1 Nutritional intervention and metabolic variables.
Plasma hypoxanthine and urate samples were taken at the post-loading 5 km time trial
(TT3). The levels of these plasma metabolites were compared to the concentrations of
plasma hypoxanthine and urate that were sampled at TT2 and between the creatine and
placebo groups (see Fig. 8 and Fig. 9). The plasma hypoxanthine levels were significantly
different from rest at the recovery time points zero, 4, lO and 20 minutes in both the
creatine and placebo groups (P<O.OOOI).The creatine and placebo groups were not
different from each other for either the pre- or post tests or the response over time.
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Plasma urate concentration changed over time (P<O.005) and the time effect was not
different for pre- and post tests. There was a significant group effect with the creatine
group showing lower urate concentrations in the post test that was not apparent for the
placebo group who tended to have higher values for the post test.
Figure 8: The comparison of plasma hypoxanthine concentrations pre- and post the 7 day
loading period in the placebo (n=6) and creatine (n=7) groups. (Table of means ± SD in
Appendix 9). * P<O.OOOI (significant time effect)
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Figure 9: The comparison between plasma urate concentrations pre-and post the 7-day
loading period in the placebo (n=6) and creatine groups (n=7). (Table of means ± SD in
Appendix 9)
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8.3.2 Muscle data
Muscle was analyzed in this study to determine total intramuscular creatine concentration
and total intramuscular nucleotide concentration between the placebo and creatine
groups. The creatine group showed a non-significant increase (7%) in mean total
intramuscular creatine concentration.
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Figure 10: Intramuscular total creatine concentration (mean and SD) in both the placebo
(n=6) and creatine groups (n=4) pre-and post supplementation. (Table of means ± SD in
Appendix 10).
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Total intramuscular nucleotide concentration was also analyzed. No significant
differences were found in the mean values for total nucleotide concentration (the sum of
ATP and ADP as no AMP was found in the muscle analysis) pre- and post loading in the
creatine and placebo groups. Creatine group values were 23.2 ± 6.l mmol/kg dry wt pre-
loading and 24.2 ± 2.7 mmol/kg dry wt post-loading. The placebo group showed a similar
trend with 24.2 ± 2 mmollkg dry wt pre-loading and 25.3 ± 1.9 mmol/kg dry wt, post
loading.
The mean % MHC isoform distribution was also calculated for all the subjects inboth the
creatine (n=7) and placebo groups (n=6) (see Fig. II)
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FIGURE Il: The % MHC distribution between the creatine (n=7) and placebo groups
(n=6). (Table of means ± sn in Appendix 10).
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CHAPTER 9: Discussion
9.1 Study 1
For road cycling the capacity to perform a "sustained sprint" is important during the race
if an attempt is made to catch up with a pack of cyclists some distance ahead, or if a
break away is attempted. However, "sustained sprint" capacity is not usually measured in
the laboratory. We have used the 5 km TT as a measure of "sustained sprint" capacity
and determined what factors may influence this capacity.
The following is a summary list of the major findings: i) There was a significant
difference between STmean and TTmean due to the effect of prior fatiguing on
subsequent exercise time trialing performance. ii) There was a good relationship between
PSPO and 5 km time trial performance in the fresh (TTmean) as well as in the fatigued
state (ST mean), although the relationship was statistically better in the fresh condition.
iii) There was a statistically significant correlation between %MHC composition and
plasma lactate concentration at time zero of recovery. The greater the %MHC I the higher
the plasma lactate concentration at time zero.
Fatigue, induced by stochastic exercise definitely altered time trialing performance. All
subjects (n=13) slowed their performance times between ST mean and TT mean with
individual differences of 38 s at the top end of the scale to a single second as the smallest
difference recorded. The fact that the subjects slowed down, was in itself an expected
result. However, the extent that the subjects slowed down was so variable that we also
determined whether this was related to any physiological variables, see later.
Only one other study that I am aware of has evaluated time trial performance following
stochastic exercise. Palmer et al. (1997), evaluated the effects of stochastic versus steady-
state exercise on subsequent time trialing performance. There are several aspects in
which the study by Palmer et al. (1997) differed from the current study, making
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comparison of actual results difficult. Firstly, in the study by Palmer et al. (1997) the time
trialing distance was 20 km long and the stochastic test was a lot longer (150 min vs.
32min). Secondly, they did not evaluate the fatiguing effect of stochastic exercise relative
to the fresh condition as I have done, but compared the fatiguing effect of stochastic
exercise vs. steady state exercise of similar duration and average intensity on subsequent
time trial performance. However, despite the similar work that was done in steady state
prior to the time trial, they found that stochastic exercise was a more fatiguing form of
exercise to do prior to a time trial.
The implications of doing laboratory testing that includes both fatiguing stochastic work
and a time trial are that this type of testing, tests more than just "power" performance but
also resistance to fatigue at various work intensities that may relate to various recruitment
patterns. Therefore, possibly a more "complete" testing method. However we were
unable to relate the extent of decrement in time trial performance following stochastic
exercise to any physiological variable that we measured. It may be that not all the
subjects performed similar amounts of high intensity work during training and that the
design of the training programme (which I did not determine) is the main factor affecting
the fatiguing effect of stochastic exercise. Stepto et al., (1999), investigated the effect of
varying the intensity of interval training on 40 km time trial performance in endurance
cyclists. Their results showed that training that included several work bouts of 4 min
duration at race pace resulted in the greatest enhancement of performance in a simulated
40 km time trial and also in the incremental test to determine peak power. It is therefore
possible (even probable) that interval training would also affect time trialing performance
after stochastic exercise.
In the current study the time trial distance was a lot shorter in length than those in the
above mentioned studies. The 5-km time trial was extremely taxing on the cyclists as can
be seen in the lactate levels produced (Fig. 2). This suggests that the energy for power
production was not entirely supplied by the aerobic system in the 5 km time trial, but that
the non-oxidative glycolytic system was used to a large extent. This type of exercise is
often associated with high levels of hydrogen ion production (Neville et al., 1989) and
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therefore, performance may be affected by muscle buffering capacity, which we did not
have enough muscle to measure. The addition of high intensity workloads as part of the
fatiguing stochastic exercise, would also produce hydrogen ions and it is possible that the
endogenous buffering capacity was already partly utilised prior to the ST time trial, thus
affecting performance and explaining the decrement.
Another finding in the current study was the significant correlation between PSPO and
TT mean and PSPO and ST mean. The higher the PSPO value, the faster the time trial
performance time whether fatigued or not. The correlation between PSPO and TT mean
was similar to the correlation that Hawley and Noakes, (1992) achieved for PSPO and
20km time trial speed were 1- -0.79, P<O.Ol and r= 0.68, P<O.Ol respectively. A possible
reason for the slightly better correlation between PSPO and 5-km time trial (fresh) than
for the 20km time is that the PSPO test and the 5-km time trial were very similar in
duration (time trial times were7 min 13 ± 13.2 s for TT mean compared to PSPO mean
time for n=13 of 10 min 26 ± 1.5 s). It could be said that the metabolic requirements for
both tests were fairly similar. If this is the case, it is perhaps not surprising that STmean
showed the worst correlation with PSPO than did TTmean (r= -0.60, P<0.05 and 1- -0.79,
P<O.Ol respectively). Both the power energy provision for STmean are different from
those for TTmean, for example, within 40 minutes of cycling at 71± 2 % of V02peak (not
even as intense as the average workload during stochastic test or 5 km TT) a cyclist can
utilise 224 mmol/kg of glycogen Febbraio et al. (1998). Since glycogen utilisation rate
decreases as muscle glycogen concentration decreases, the substrate for the last seven
minutes of STmean would be substantially different from fresh TTmean Febbraio et al.
(1998).
The subjects PSPO/kg ratio was correlated to time trial performance and no significant
results were obtained. Therefore, it is more important to have a high muscle power per se,
than to have a high muscle power relative to own body mass. This may however not
always be the case for outdoor events. In the laboratory there is no component of wind
resistance or gravitational force such as can be present outdoors and where body size per
se could be a disadvantage. A surprising result was that the lO5-km performance time
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prediction was not at all related to any of the exercise performance variables (Table 2 in
section 7.2.3). A possible similarity was hypothesised (prior to testing) between the time
trial in the fatigued state (ST) and 105-km performance time. The 105-km mass start
cycle race used as a criteria for the selection of the subjects also entailed variations in
work intensities as was found by Palmer et al., (1994). However the duration of the race
was considerably longer (183.5± 11.3min) than the laboratory test in this study (32min +
7min 32 sec± 14.7 sec). The implication of this finding is that short duration laboratory
tests can seldom be relied on to predict performance in races of longer duration.
There were significant changes in the plasma lactate concentrations from rest to exercise
that lasted throughout the twenty minutes of recovery recorded in this experiment. The
most interesting factor is that the mean plasma lactate recorded 20 minutes after exercise
had ceased, was still 9.09 ± 2.02 mmolIL indicating that all subjects had failed to return
to a value even close to an expected resting value. We hypothesise that lactate release
from the muscle was prolonged. A possible explanation for our finding is that it is
relative to that typically seen after an incremental PSPO test to fatigue. There plasma
lactate concentration has an exponential decay rate after peak concentrations are reached
approximately two minutes post-exercise due to saturation of the transport proteins,
monocarboxylate transporters 1 and 4 (MCT 1 and MCT 4) (Bonen et al., 1997). Muscle
oxidative capacity was unrelated to plasma lactate disappearance rate during recovery.
Therefore, we conclude that prolonged high levels of muscle lactate release
overshadowed any influence of plasma lactate disappearance and subsequent oxidation
on plasma lactate concentration itself.
In the current study plasma concentrations of hypoxanthine and urate increased during
maximal exercise and recovery which is consistent with previous literature (Patterson et
al., 1982, Hellsten-Westing et al., 1989; Strathis et al., 1994). The increase in plasma
hypoxanthine (precursor of xanthine and urate) during exercise and the further
continuous increase during recovery is consistent with previous findings after maximal
short-term exercise (Sollevi 1986; Patterson et al., 1982; Hellsten-Westing et al., 1989).
In a different study, the relative increase in xanthine (3-fold) and urate (10%) were much
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less than for hypoxanthine (27-fold) (Sahlin et al., 1991). The interesting observation in
the present study was that the highest mean concentration of hypoxanthine was at the 10
minute time point after termination of the exercise with a peak value of approximately 50
umollL. This is almost double the mean value obtained by Sahlin et al. (1991), who
reported a peak value of 24.2 ± 2.2 umol/L attained 10 minutes after exercise into
recovery. Their subjects cycled at a power output calculated to elicit 40% and 70% of
V02max for 6-7 minutes each, where after the power output was increased to that
calculated to correspond to 100% V02max, this exercise intensity being maintained to
fatigue. The continuous response may be a consequence of the low activities of 5'-
nucleotidase and nucleotide phosphorylase, which catalyse the transformation of IMP to
inosine and from to inosine to hypoxanthine, respectively (Sahlin and Katz, 1988) so that
conversion is saturated easily during exercise and must therefore continue after exercise
to clear IMP and is still high after 20 minutes. The area under the curve calculated for
hypoxanthine was not related to TT2, but was related to %MHC Ha (r = 0.56, P<0.05)
thus we can conclude that fast twitch fibres are accumulating more ADP or maybe have
more AMP dearninase to convert AMP to IMP and subsequently to hypoxanthine.
It has been shown in previous studies that the decrease in the adenine nucleotide pool
during maximal maximal exercise is about 15% and that a corresponding increase in IMP
occurs (Sahlin et al., 1991). In other studies arteriovenous differences across the
previously exercised muscle of xanthine and urate are not significantly different from
zero and imply that oxidation of hypoxanthine occurred in other tissues than the working
muscle (Hellsten-Westing et al., 1989; Strathis et al., 1994). In summary, a 5 km TT,
firstly produces substantial hypoxanthine and urate relative to other fatiguing exercise.
Secondly, it results in prolonged high post-exercise hypoxanthine concentration, which
are, thirdly related to % MHC Ha.
Muscle MHC composition also had a significant effect on plasma lactate concentrations.
Immediate post-exercise lactate concentration correlated % MHC I (r=0.59, P<0.05) and
% MHC Ha (r= -0.61, P<0.05). The correlation between lactate at time zero of recovery
was positive with type I, so those with the highest slow twitch fibre ended up with the
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highest lactate concentration at the end of the exercise. This is unlikely to be related to
lactate production by the muscle fiber type itself because type Ha fibres have a higher
capacity to produce lactate (Jensen-Urstad et al., 1994). A possible alternative
explanation for these results is that lactate transport capacity out of the working muscle is
greater in type I than type Ha fibres. In support of this possibility is the data of Pilegaard
et al. (1999) who showed that MCT 1 content correlates positively with % fibre type 1.
However, the issue is more complex than that , since MCT 1 can occur in the
sarcolemmal and mitochondrial fractions (Dubouchaud et al. 2000). Dubouchaud et al.
(2000) have shown that lactate release by muscle working at 65% V02peak is correlated
positively with MCT 1 and MCT 4 contents in the sarcolemma.
Correlation analyses suggest a relationship between histochemically assessed percentage
fiber type area and the electrophoretic ally assessed MHC content in human limb
musculature (Fry et al., 1994). In this study the relationship between percentage fibre
type and the MHC content did not match up completely. The sample size for this analysis
was one and was done as a case study. However because of possible histochemical
misclassification of some fibers (especially trained muscle) both techniques may be
important in yielding information about fiber type composition and possible fiber type
transformations.
9.2 Study 2
In this study we determined whether oral creatine supplementation would affect 5-km
time trial performance in the fresh condition after stochastic testing as well as whether it
would affect metabolism during and recovery after 5 km TT. Based on a similar creatine
loading regime to that first described by Harris et al. (1992), the trials were conducted.
The exercise performed in this research project was of an extremely high intensity and
continued for 7-8 minutes when just the 5-km time trial was conducted and 39-40
minutes when the stochastic test was conducted with the 5-km time trial. It is likely that
energy was provided by several of the energy systems from the pathways involving the
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use of high-energy phosphates, adenine nucleotide metabolism, the glycolytic pathway
and the oxidative pathway. Most of the research on creatine and performance has focused
on high intensity short duration exercise «30 s) (Balsom et ai, 1993; Greenhaff et ai,
1994; Dawson et ai, 1995; Prevost et ai, 1997) as well as more prolonged high intensity
exercise (>30 s <150 s) (Febbrario et ai, 1995 and Jacobs et ai, 1997). Aerobic (>150 s)
studies and creatine supplementation have also been completed (Barnett et ai, 1996;
Bellinger et ai, 2000; Godly and Yates, 1997). Studies on creatine supplementation and
5-km time trial performance had not been conducted, to my knowledge, to date.
The results that we achieved to test our hypothesis that creatine supplementation would
improve time trial performance after stochastic exercise showed that both groups slightly
improved in their 5-km performance times in the fatigued state (ST mean vs. ST3) but not
statistically significantly. Therefore the hypothesis is rejected. Balsom et al. (1993b),
proved that creatine supplementation does not enhance endurance exercise performance.
They investigated the influence of creatine supplementation on performance during a
supramaximal run on a motor-driven treadmill until exhaustion and an approximate 6km
terrain run. They mentioned that a likely explanation for a decrease in performance could
perhaps be explained by an increase in body mass, which might have been the case in this
study, although body mass change would be more likely to affect running than cycling.
As mass was not monitored in the current study it thus can not be related to the
performance times. Within the placebo group four subjects showed improvements in
performance times (subjects 3,6,8, 13) and two did not (subjects 10 and 12) with subject
10 being 19 seconds slower. It could have been that the subjects of both groups were
becoming more trained as the study continued and thus there were no significant
differences in the data. The variation could also have been because the subjects thought
that they might have been on creatine rather than placebo and therefore tried harder.
Within the creatine group three subjects improved their performance times (subjects 1, 2
and 4) and four subjects marginally decreased their performance times (subjects 5,7,9,
and 11). Therefore our study confirms that exercise performance with a large aerobic
component is not affected by creatine supplementation (Stroud et al.; 1994, Bellinger et
al. 2000). Our results suggest that 5 km TI does greatly affect adenine nucleotide
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metabolism in the baseline, unloaded condition. In both tests TT2 and TT3 the
hypoxanthine levels increased over time (Stathis et al, 1994) and were at high levels
during recovery and remained so, even 20-min into recovery time, an indication of the
intensity that the 5-km time trial exerted on adenine nucleotide degradation (Fig. 8).
Another finding in this study was that the creatine loading had no effect on the alteration
of the metabolism of plasma hypoxanthine and urate when comparing pre vs. post
loading and the group effect. This is in contrast to what has been shown by Balsom et al.,
(1993); Greenhaff et al, (1993) in short term exercise and Bellinger et al. (2000) who
found that plasma hypoxanthine was reduced (P<0.01) in the creatine group over time in
the one hour cycle test after loading. One difference from the current study is that they
did have a larger sample group (n=21). A possible reason for a non significant result for
hypoxanthine could be the large standard deviations. The slight alteration in metabolism
did not improve the 5-km time trialing performance.
With the increase in plasma hypoxanthine there is the concurrent release and increase in
plasma urate. The concentrations of urate did not increase much in comparison to that of
hypoxanthine, but the values of urate remained high throughout recovery and plateaued
and remained so even at minute 20 of recovery (Fig. 9). This study showed a significant
difference between the concentrations at the different time points. There was also a
significant difference between the groups in the pre-and post tests. In the placebo group
the plasma urate concentrations during TT3 were significantly higher that during TT2. In
the creatine group the mean values of urate during TT3 were significantly lower than
during TT2 (P<0.005). Thus creatine supplementation did have an effect on the plasma
urate concentrations, which is in contrast to what Bellinger et al. (2000), found due,
possibly, to the complex kinetics between muscle hypoxanthine production and release
and urate formation
Total intramuscular creatine concentration was also determined. Creatine
supplementation as described by Harris et al., (1992), showed an increase of 20% (30%
of this increase being attributed to an elevation in CP storage) which has also been
confirmed by Greenhaff et al., (1993). In this study the creatine group showed a non-
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significant increase of 7% in mean total intramuscular creatine concentration (Fig 10).
There are several explanations for this non-significant loading effect. Firstly, the initial
value of the creatine group was relatively high (132.76 mmol/kg/dry wt) and it has
previously been shown that subjects with lower baseline values load more than subjects
with higher baseline values (Harris et al., 1992; Delanghe et al., 1989). Secondly, we had
a small sample size (n= 4). Such values possibly occurred due to the creatine group
sample being made smaller as a result of samples having defrosted. However this
unavoidable circumstance was not the only influence on the significance of the result
since there were also two non-responders in the creatine group that was left. The highest
total creatine value attained by one of the subjects was 165 mmol/kg dry wt which
surpasses the maximal level thought to exist by Harris et aI, (1992), of 150-160 mmol/kg
dry wt, but only by a very small margin.
The mean concentrations of total nucleotide in the rested muscle did not differ much after
the loading week, with a less than a 1% mean increase in both the creatine and placebo
groups. The above result is expected as the effect of creatine supplementation is not to
affect ATP concentration itself but to indirectly affect potential energy for ATP
buffering. Some individuals varied total nucleotide levels by more than 1% and therefore
as was seen in the methods section, creatine levels were corrected to an equal nucleotide
value for each individual.
Plasma lactate concentrations were not analysed in this study as previous studies have
shown that these values can remain unchanged (Birch et al 1994; Odland et al 1994)
following oral creatine supplementation. The fact that plasma lactate levels are
unchanged implies that there has been no alteration in non-oxidative carbohydrate
metabolism in response to Cr loading. Two studies have shown a decrease (Balsom et al,
1993; Sëderund et al., 1994). This could be that the exercise duration was so short that
one could influence the onset of glycolysis by having more PCr around, thus delaying
even by 1-2 seconds the onset of lactate accumulation. If the exercise duration is longer
than 10 seconds this effect would not occur. In contrast, one study has shown lactate
values to increase with creatine loading (Greenhaff et al., 1994). The greater lactate
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concentrations could be explained by either higher body mass to carry over the exercise
terrain or more work done in the time because of creatine supplementation delaying
fatigue.
9.3 Conclusions
The performance of the cyclists was monitored for the stochastic tests plus time trials as
well as time trials in the unfatigued condition. The results of this study indicate that these
tests were highly repeatable. The performance tests also resulted in high values for
lactate, hypoxanthine and urate, an indication of fatigue achieved in the performance tests
or possibly an indication of the high extent of anaerobic energy provision. These data are
of the first to show an indication of the saturable nature of lactate release by muscle and
the finding lends itself to further investigation.
Nutritional intervention of daily oral creatine supplementation of 20g of creatine for a 7
day period did not improve performance significantly in the stochastic 5-km time trials or
the individual 5-km time trials. The results of this study may have been affected by
several factors. The small sample size which may have reduced the statistical power of
this study. However, financial constraints limited the amount of subjects that could
participate in the study. Technical problems were also encountered during the study.
Unfortunately, some of the muscle samples were lost due to the unexpected failure of the
ultra-freeze refrigerator. These samples had to be discarded on the basis that normal
values for muscle metabolites were not measured and thus affected the individual values
for creatine, creatine phosphate and the adenine nucleotides. This resulted in the loss of 3
creatine loading subjects' data from the muscle analyses. However given the really large
lactate responses to the 5 km TT and the less dramatic hypoxanthine and urate reponses
under baseline conditions, it may not be advisable to repeat the creatine loading study.
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Appendix 1
Information sheet.
Project title: The effect of creatine supplementation on time trial performance after
stochastic exercise.
Masters student: Andrew de Pao (under the supervision of Prof. K.R. Myburgh.)
Basic Protocol:
Week 1: Peak power output test (PPO) on an electro-magnetically braked cycle ergo-
meter (Mon/Tues)
1st baseline stochastic test with S-km time trial directly afterwards. (ThurslFri)
(The stochastic test on an electro magnetically braked cycle ergometer and the
time trial on a ergometer such as the Spintrainer on which own bicycle will be
be attached.)
Week 2: tJd baseline stochastic test with 5-km time trial directly afterwards. (Mon)
1st baseline 5-km time trial. (Wed)
2nd baseline 5-km time trial. Blood samples to be taken. Muscle biopsy to be
conducted 1-2 hours post exercise.(Fri)
Week 3: Creatine loading for a week and training to be carried on as per usual.
Week 4: Final stochastic test with 5-km time trial (Monffues)
Final 5-km time trial. Blood samples to be taken. Muscle biopsy to be
conducted
1-2 hours post exercise.
• A muscle biopsy is a small surgical technique, which will be performed by a medical
doctor experienced in this technique. It will be performed under sterile conditions
and training will not be affected for more than one or two days.
• Blood samples will be taken during and after the 5-km time trial under sterile
conditions.
• A maintenance dosage of creatine will also be given to the subjects after the loading
week. (maintenance dosage = another week of creatine)
• During the whole study there should be no alteration in your training regimen.
• Avoid heavy training the day before each test.
Contact details:
Exercise Physiology Laboratory 808 4564 or 808 3149 (Dr. Myburgh).
Andrew de Pao 0827143171 or 5544105
Muscle biopsies performed by Dr. J.C. Koenig 883 2564
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Appendix 2
CONSENT FORM
Exercise Science Laboratory,
Department of Human and Animal Physiology,
University of Stellenbosch.
Pr~iect Title: The effects of oral creatine supplementation on time trialing performance after
stochastic testing.
Statement of understanding:
I have read and understand the explanations of procedures below. I
have had the opportunity to ask the investigator any questions and
understand that I am free to withdraw from the tests at any time
should I so choose.
I confirm that:
1. I have been invited to participate in the research project at the Physiology Department
at the University of Stellenbosch.
2. It has been eMpiained that:
2.1) The aims of this study will be to determine: The effects of oral creatine
supplementation on time trialing performance after stochastic testing.
2.2) Informed consent is required for the following procedures as part of the methods
followed in the project· opposite the description the relevant procedures are marked
X.
2.3) It is espected that this project would be completed on a total of 12 to 16
subjects
The project will ideally be completed over a period of 4weeks for each subject.
There wal be a total of at least 7visits to the exercise laboratory per week.
Each visit will last 1 hour to 2 hours.
127
Stellenbosch University http://scholar.sun.ac.za
Procedure tt Visits EXPLANATION OF PROCEDURE
Blood Drawing Blood samples will be withdrawn for chemical analysis. Each time 3-10 mlIelbow . I (1/2 to 2 teaspoons) of blood will be withdrawn with a syringe.
I I A needle will be inserted into the elbow veinINo more than samples per visit = ml ( teaspoons)
I IforearmIx I lA needle + catheter is inserted into a forearm vein, the needle is removed
and the catheter remains. samples per visit=14 (Sml per sample)
I II fingerprick I IIThe fingertip is cleaned with an alcohol swab, pricked and squeezed until
for a drop of blood. During the test the finger will be pricked times.
V02max This test is performed in the laboratory, whilst breathing via a face-mask.
Testing Maximal exercise intensity to exhaustion is required for accurate results.
I I Icycling I Ilon a cycle ergometer
I I Irunning I Ion a treadmill I
Maximum This exercise test will be performed in the laboratory.
workload Maximal exercise intensity to exhaustion is required for accurate results.
I X Ilppo I IIPeak Power Output: a continuous incremental test on a cycle ergometer
I IlpTS I IPeak Treadill Speed test: a continuous incremental test on a treadmill I
II Wingate test This test is performed at Human Movement Science on a sprint-cycle
ergometer. Max sprinting speed is required for the duration of the test
Submax Ex Test will be performed in the laboratory on 8(;ïcle ergometer or treadmill.
I II steady state I IISet workloads will be completed for the required amount of time.
I II to fatigue I IThe set submaximal workload will be continued until exhaustion. I
Intermittent This type of exercise intersperses bouts of low intensity and high intensity
Exercise exercise at set percentages of maximum.
I I Itest I As many repetitions as possible is required
Ix I Itraining I IThe set number of intervals must be performed (12 intervals) I
Time Trial Test will be performed in the laboratory on the subject's own bicycle
Ix I
mounted on a spin-trainer. The rear inner tyre of the bicycle should be
confirmed by the subject to be in a good condition.
II Field test This test will take place as a race under normal racing conditions.
II Hypoxic test During this test I will breathe a mixture of air containing 14% oxygen. This
is 213the amount usually present and is likely to make exercise more
difficult.
Specialised Dexamethasone
I I test
Muscle biopsy A small muscle sample (50 mg) for microscopic and chemical analysis will
Ix I be taken. A medical doctor will perform this minor surgical procedure after
administration rlJfr local anaesthetic. To minimize potential infections (2%
incidence; east y reated with antibiotics), it will be performed under sterile
conditions. The subject must keep dressing in place for 3 days afterwards.
Number of biopsies per visit: notal: 2
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I also confirm that:
3. I have been informed of any possible siele effects, discomfort or detrimental effects of
participating in this study.
4. All the possible advantages of the study have been explained.
5. Information gathered in this study will be confidential. No names will be associated with
individual results since every subject wmbe represented by a number unknoV\lt1to them.
The results will be used for a scientific assignment publication or thesis, or all of these.
6. Resu~s wal be made avaiable regarding the complete project as well as my own
individual results once the project is completed.
7. I am free to withdraw from the study or any procedure at any time and that the
researcher has the author~y to remove me from the project, without impeding any
participation at the relevant department in any other activity.
8. The information was presented in a language that I can understand and that I had the
opportunity to ask any questions and that my questions were answered.
9. My participation was of ~ oV\lt1choice without any pressure from the researcher I the
department and that I am allowed to withdraw at any given time.
10. My participation will not involve any personal monetary costs.
11. I am currently healthy and exercise regularly with no adverse symptoms
12. If I had a muscle biopsy, I can contact Dr J.C. Koenig at tel: (021) 883 2564 at any time
during the week following the biopsy.
L am __ years of age and hereby
give consent to undergo all of the above procedures according to the explained protocol.
Signatures:
Subject: ID _
Date: _
Address: ~=_-------
·Witness: ID Date
I, declare that
1. The information in this document has been explained to:-:---:---:---:::-- __ -:-:-__
2. That he was given the opportunity to ask questions and/or to clarify any problems.
3. That the conversation was completed in English I Afrikaans without the need of an
interpreter.
Signed at: on _
Signature: Witness: _
Exercise Science Laboratory,
Department of Human and Animal Physiology,
Uni."ersity of Stellenbosch.
Project Title: The effect of oral creatine supplemetation on time trialing performance after
stochastic testing
Statement of understanding:
1. I have read and signed the attached informed consent.
2. I understand that in addition to the results of the research, I will receive:
Tick the appticable box in the left-hand side of the table:
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Money Productl EXPLANATION
Procedurel
Value
I II I iIThis amount will be paid if I have to take pubfic transport to
reach the lab and return home
Ix II R 200-00 I This amount will be paid to coneensete for the time Ihave
invested in the project but will only be paid ~ I complete the
whole project and do not drop out of any of the tests or
[procedures.
Ix I lu~~I I will receive this product as part of the experiment OL if Ireceived placebo, I will be given the active product at the end
of the trial to take at home.
DI I Iwill receive this procedure in addition to those that are part ofthe experiment to compensate me for the time Ihave investedin the project.
SIgnatures:
Subject: 10 _ Date
Witness: ID--------- -------------- Date
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Appendix 3.
The variable fixed-workload protocol (stochastic test) was as follows:
A warm-up of 5-8 minutes at 100 Watts. The stochastic test is graphically represented
below with the amount of time spent on each workload (x-axis) and the percentage of
PSPO (y-axis).
STOCHASTIC TEST
2min 2min lmin Iminlmin 4min
(Total time 32min)
On completion of the 32 minute stochastic test the subjects performed a 5 km time trial
in the fastest possible time.
131
Stellenbosch University http://scholar.sun.ac.za
Appendix 4
Freezing tissue for histochemistry.
The following equipment is needed:
Approximately I-litre of liquid nitrogen
Isopentane
Tissue Tek® mounting compound
One pair of long-handed tongs
Scalpel blade
One pair of forceps
One large thermos flask
One small metal container
Corkboard
35 mm film canister
Cutting board
Shaved ice
The freezing procedure is as follows:
1. Place the liquid nitrogen in the thermos flask and isopentane in the metal container.
2. Slowly lower the metal container into the liquid nitrogen and allow the isopentane to
freeze until there is a pool of unfrozen isopentane in the centre. This creates optimum
freezing conditions.
3. Place the muscle tissue on the cork with the orientation of the fibres being vertical
and apply the Tissue Tek® mounting compound around and on top of the tissue
sample.
4. Now place the tissue upside down into the pool of isopentane for 30-seconds so that
the muscle comes into contact with the isopentane first.
5. Place the frozen sample into a film canister with some shaved ice (to decrease the
rate of dehydration upon storage) and store it at -80°C.
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Appendix 5
Myosin ATPase staining procedure.
Firstly the solutions have to be made up.
Solution A Veronal buffer pH 9.4
50 ml 0.1 M sodium barbitone
50 ml 0.18 M CaCh
150 ml distilled water
Adjust the pH to 9.4 with 0.1 M HCl or 0.1 M NaOH
Solution B: 0.2 M Acetate buffer
0.2 M acetic acid
0.2 M sodium acetate
For pH 4.3: 40 ml 0.2 M acetic acid
20 ml 0.2 M sodium acetate
For pH 4.6: 20 ml 0.2 M acetic acid
40 ml 0.2 M sodium acetate
Adjust the pH with 0.1 M HCI or 0.1 M NaOH
Solution C: Substrate incubation solution.
10 ml 0.1 M sodium barbitone
5 ml 0.18 M CaCh
35 ml distilled water
150 mg ATP (di-sodium salt)
Leave the substrate solution at 37°C to warm, then adjust to pH 9.4 with 0.1 M HCI or
0.1 MNaOH as required.
NOTE: The substrate solution must be made up fresh before use.
The staining procedure is as follows:
1. Pre-incubate the cryostat sections in the buffer of the appropriate pH for l5-minutes.
2. Take the sections from pH 4.3 and pH 4.6 buffers and rinse them in pH 9.4 buffer.
3. Incubate all the sections in pH 9.4 buffer for 5-minutes.
4. Now remove the sections from the pH 9.4 buffer and place them in the pre-warmed
substrate solution at 37°C in a humid chamber for the appropriate times: pH 9.4 for
8-min, pH 4.6 for 12-min and pH 4.3 for 24-min. It is important to shake every 5-min
to prevent CaCh precipitates from producing uneven staining.
5. Wash well in 0.09 M CaCh for 3-minutes.
6. Place in 2 % cobalt chloride for 3-minutes.
7. Wash well in 0.01 M sodium barbitone solution.
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8. Rinse in distilled water and collect in a slide rack.
9. Develop colour on the slides using a dilute (approximately 1 %) ammonium sulphide
in a fume cupboard for 30-seconds.
10. Wash in running water for lO-minutes.
11. Counter stain only the pH4.3 sections in eosin.
12. Rinse thoroughly in tap water.
13. Dehydrate the slides with ethanol of different percentages, 70 %, 90 % and 96 % in
that order.
14. Clear the slides in xylol
15. The slides are now mounted with mounting gel.
The fiber typing results for one of the subjects was as follows at the various pH levels:
pH4.3 pH4.6 pH9.4
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Appendix 6
Muscle MHC separation using Sodium Dodecyl Sulphate (SDS)=polyacrylamide gels.
The SDS-gels consisted of two gels, a separating gel and a loading gel as well as a
denaturation buffer that were made up of different reagents.
The separating gel consisted of the following:
8 % acrylamide (w/v)
0.08 % bis-acrylamide (w/v)
0.4 % SDS, 0.2 mM
Tris-base (pH 8.8) ,and
27.5 % glycerol.
The loading gel consisted of the following:
3 % acrylamide (w/v)
0.16 % bis-acrylamide (w/v)
0.1 % SDS
125 mM Tris-base (pH 6.8).
The denaturation buffer consisted of
10 % glycerol (w/v)
5 % J3-mercaptoethanol (v/v)
2.3 % SDS (w/v)
62.5 mM Tris-HCl (pH 6.8) and
0.02 % bromophenol blue and heated for 10 minutes at 60°C.
An example of the separation of the 3 MHC isoforms found in human skeletal muscles:
ITx
ITa
I
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Appendix 7
An example of a chromatogram for both A) a muscle standard solution and B) muscle
sample at 210nm
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An example of a chromatogram for both A) a muscle standard solution and B) muscle
sample at 249nm
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An example of a chromatogramfor both A) a plasma standardsolution and B) plasma
sample at 249nm
A)
C'. 020.l'J.•..
0.01.80-
0.0160
0_oi40.·1
i
1
0 ..0120---;:
1
1
O~Ol.D01 Hx
Ur
I
!
:
0.000°1
,{
o. (,G60 4
1
''1
0.0040.J
j
1 . ..• -'",""1- ··:·:.···.,..-·-r'·'·-·_·~T~-'-~·--r··_-;'· __·..···_·,.-·-
2_00O.GO .lj .. 00
T"""
6_00
-:--:'~-"--:--~:-:-;:-::~"'i:i
8.00 10.00
Time (min)
B)
r--·-----------·-·..
o . oeso'
j
o_o600J
I
0_ G5so-1
O.0500~
...... _ ..._---_ ......~..._ ...._--
,
o . 04.50---1
<
0 ..04.f.Hj .~
j
n o-c(l~,'" 3-'~l
0.0300:1
i
O.t.J2S0j
1
o-.0:200"i-
i
O. Ol ,,0 i Hx j i
('.010
i
) i {\. J (
G. oos 0'1 ....-.~,.......,_"t--_.~J_~:.,,__~.~,,- ...---""----~---_. __ ._j
+~;:r-::-::--·M._:~.~~ ..::-;::-..::.::_=:-::---:-_- i ,," - '~-~--~'·"T·-·--.--------r----··T·' --_..__._~-_,....--:--.. _._._,_--:-_1
o~oo 2.00 4.00 6_00 8_00
Time (min)
138
Stellenbosch University http://scholar.sun.ac.za
Appendix 8
The table of means + SD for the 5 km time trials in the fatigued state (ST) and the
individual 5 km time trial (TT). (Fig. I)
• ,'1,
,,','
7:24.0
7:02.0
7:25.5
7:05.0
7:31.0
6:55.0
The table of means + SO for the individual 5 km time trial (TT mean and TT3)
performances before and after the loading week. (Fig. 6 and Fig. 7)
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Appendix 9
The table of means + SD for plasma lactate concentrations taken at TT2. (Fig.2)
mean 1.48
sn 0.70
12.91
2.07 2.48 2.49 3.00 2.82
7.68 13.46 13.27 12.48 11.07 9.09
3.83 1.79
The table of means + SD for plasma hypoxanthine concentrations taken for TT2 and TT3
(pre and post loading). (Fig. 3)
The table of means + SD for plasma urate concentrations taken for TT2 and TT3 (pre and
post loading). (Fig.4)
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Appendix 10
The table of means + SD for Creatine, creatine phosphate a Total creatine concentrations
pre and post loading. (Fig.lO).
The table of means + SD for total nucleotide contents pre and post loading. (fig. II).
The table of means + SD for % MIlC distribution in the vastus lateralis. (fig. 12) .
. - 0.-. '.:':'"':.;' ....
1.67
'i'"'' ..• ".::..:..
0.0
4.41
0.0
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